cephalosporin c has been researched along with imipenem, anhydrous in 406 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 79 (19.46) | 18.7374 |
1990's | 145 (35.71) | 18.2507 |
2000's | 91 (22.41) | 29.6817 |
2010's | 61 (15.02) | 24.3611 |
2020's | 30 (7.39) | 2.80 |
Authors | Studies |
---|---|
Girlich, D; Leclercq, R; Naas, T; Nordmann, P | 1 |
Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
Hanberger, H | 1 |
Nikoskelainen, J | 1 |
Dolna, I; Ruczkowska, J | 1 |
Allard, S; Auger, F; Bisson, C; Daviau, N; Drapeau, C; LeBel, M; Paradis, D; Vallée, F | 1 |
Casiraghi, S; Caspani, P; Germiniani, R; Pace, M; Rosina, M; Tajana, A; Trabucchi, E | 1 |
Katsu, K; Watanabe, N | 1 |
Hiruma, R; Katsu, K; Watanabe, N | 1 |
Edlund, C; Hedberg, M; Lindqvist, L; Nord, CE; Rylander, M | 1 |
Inoue, E; Iyobe, S; Katsu, K; Mitsuhashi, S; Watanabe, M | 1 |
Harabe, E; Kanazawa, K; Kawai, Y; Nishino, T; Otsuki, M | 1 |
Hopkins, JA; Lami, JL; Wilson, SE | 1 |
Cherubin, CE; Eng, RH; Smith, SM; Tan, EN | 1 |
Andrews, JM; Baldwin, DR; Cooper, MA; Thornber, D; Wise, R | 1 |
Knothe, H; Shah, PM | 1 |
Hanberger, H; Maller, R; Nilsson, LE; Nilsson, M | 1 |
Barrett, MS; Briggs, BM; Erwin, ME; Johnson, DM; Jones, RN | 1 |
Mitsuhashi, S; Sumita, Y | 1 |
Ishii, J; Lei, Y; Nakae, T; Satake, S | 1 |
Briedigkeit, H; Halle, E | 1 |
Kobayashi, J; Kouda, M; Kumagai, I; Matsuzaki, H; Sugai, R | 1 |
Charak, BS; Louie, R; Malloy, B; Mazumder, A; Twomey, P | 1 |
Igari, J | 2 |
Bale, MJ; Doebbeling, BN; Pfaller, MA; Wenzel, RP | 1 |
Cunningham, MD; Darveau, RP | 1 |
Pizzo, PA; Rubin, M | 1 |
Mitsuhashi, S; Yoshida, M | 1 |
Ikemoto, H | 1 |
Inoue, M; Matsui, H; Okubo, T; Sakurai, N; Tsunoda, M | 1 |
Fujita, S; Tonohata, A | 1 |
Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G | 1 |
Rosenblatt, JE | 1 |
McCracken, GH; Mustafa, MM | 1 |
Beumer, H; Hoepelman, IM; Rozenberg-Arska, M; Verhoef, J; Visser, MR | 1 |
Labia, R; Morand, A; Sirot, D; Sirot, J; Thabaut, A; Tiwari, K | 1 |
Karrer, FM; Lilly, JR; Rothenberg, SS; Schroter, GP | 1 |
Dornbusch, K; Göransson, E; Kronvall, G; Mörtsell, E | 1 |
Morooka, T; Oda, T; Shigeoka, H | 1 |
Traub, WH | 1 |
Klastersky, J; Van der Auwera, P | 1 |
Forsgren, A; Persson, KM | 1 |
Chin, NX; Labthavikul, P; Neu, HC | 1 |
Brickley, X; Duval, J; Legrand, P; Orsoni, A; Soussy, CJ | 1 |
Drusano, GL; Schimpff, SC; Standiford, HC | 1 |
Bale, M; Howard, W; Koontz, F; Pfaller, M; Preston, T | 1 |
Andrews, JM; Piddock, LJ; Wise, R | 1 |
Chin, NX; Neu, HC; Novelli, A | 1 |
Perronne, C; Vildé, JL | 1 |
Jorgensen, JH; Maher, LA; Ramirez, PE; Redding, JS | 1 |
Andrew, JH; Downes, J | 1 |
Bakken, JS; Clark, RB; Hori, M; Sanders, CC | 1 |
Amicosante, G; Frère, JM; Galleni, M | 1 |
Adelman, DC; Beall, GN; Rohr, AS; Saxon, A | 1 |
Chin, NX; Neu, HC | 2 |
Alvarez, ME; Bodey, GP; Hsu, KC; Rolston, KV | 1 |
Neu, HC | 4 |
Bodey, GP; Ho, DH; LeBlanc, B; Rolston, KV | 1 |
Roselle, GA | 1 |
Cynamon, MH; Palmer, GS; Sorg, TB | 1 |
Craig, WA; Gudmundsson, S; Vogelman, B | 1 |
Durgham, SM; Ishag, AJ; Shibl, AM | 1 |
Eley, A; Greenwood, D | 1 |
Pijck, J; Vuye, A | 1 |
Abbate, GF; Alagia, I; Cristiano, P; Giaquinto, E; Leonessa, V; Savioli, L | 1 |
Cullmann, W; Dick, W | 2 |
Starr, SE | 1 |
Bauernfeind, A | 1 |
Andrew, JH; Dixson, S | 1 |
Bannatyne, RM; Cheung, R | 1 |
Freimer, EH; Gilardi, GL; O'Donnell, ED; Raeder, R | 1 |
Cynamon, MH; Granato, PA | 1 |
Brown, JE; Collins, CD; Del Bene, VE | 1 |
Munro, R; Shanker, S; Toohey, M | 1 |
Gadebusch, HH; Shungu, DL; Weinberg, E | 1 |
Gilchrist, MJ; Spelhaug, DR; Washington, JA | 1 |
Cherubin, CE; Corrado, ML; Landesman, SH | 1 |
Verbist, L; Verhaegen, J | 1 |
Hanslo, D; King, A; Phillips, I; Shannon, K; Warren, C | 1 |
McCloskey, RV; Trent, JA; Tutlane, VA | 1 |
LeFrock, JL; Miller, MA; Vercler, MJ | 1 |
Frère, JM; Ghuysen, JM; Kelly, JA; Klein, D | 1 |
Braveny, I; Elsser, R; Machka, K | 1 |
Maskell, JP; Nasu, M; Williams, JD; Williams, RJ | 1 |
Neu, HC; Prince, AS | 1 |
Cherubin, CE; Corrado, ML; Gombert, ME; Shulman, M; Sierra, MF | 1 |
Ahonkhai, VI; Cherubin, CE; Shulman, MA; Sierra, MF | 1 |
Pranada, F; Pusztai-Markos, Z | 1 |
Finegold, SM; Owens, WE | 1 |
Meyer, RD; Pasiecznik, K | 1 |
McCracken, GH; Olsen, KD; Sakata, Y; Thomas, ML | 1 |
Bal, M; Panja, K; Ray, B | 1 |
Finan, M; Miller, MA; Yousuf, M | 1 |
Alford, RH; Brown, TH | 1 |
Alford, RH | 1 |
Chau, PY; Ling, J; Ng, WS | 1 |
Elliott, TS; Greenwood, D | 1 |
Le Noc, D; Le Noc, P; Robert, J | 1 |
Ahonkhai, VI; Bokkenheuser, VD; Cherubin, CE; Mosenthal, AC; Shulman, MA; Sierra, MF | 1 |
Bertram, MA; Bruckner, DA; Young, LS | 1 |
Vuye, A | 2 |
Schoenewaldt, EF; Smith, GB | 1 |
Gutiérrez-Núñez, J; Harrington, PT; Ramirez-Ronda, CH | 1 |
Cynamon, MH; Palmer, GS | 2 |
Cobbs, CG; Ennis, DM | 1 |
Chahime, H; Guibert, M; Labrune, P; Odièvre, M; Petit, J | 1 |
Cony Makhoul, P; Darmaillac, V; Fourche, J; Maugein, J; Perrier, F | 1 |
Hikida, M; Kawashima, K; Mitsuhashi, S; Nishiki, K; Yamazaki, Y; Yoshida, M | 1 |
Diaz, E; Garcia-Curiel, A; Infante, P; Lopez, JD; Muñoz, M; Silva, JJ; Soult, JA; Valderrabanos, ES | 1 |
Baquero, F; Cantón, R; García de Lomas, J; Gimeno, C; Liñares, J; Martínez-Beltrán, J; Tubau, F | 1 |
Chimura, T | 1 |
Munakata, K; Satoh, M; Takeuchi, H; Yoshida, O | 1 |
Jones, RN; Marshall, SA | 1 |
Kaufmann, ME; Mentis, AF; Tzelepi, E; Tzouvelekis, LS | 1 |
Bressolle, F; de la Coussaye, JE; Eledjam, JJ; Galtier, M; Kinowski, JM; Wynn, N | 1 |
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, K; Suzuki, Y; Yokota, N | 1 |
Kanno, M; Kawabata, T; Sobu, K; Takase, Y; Watanabe, T; Yoshida, T | 1 |
Blahová, J; Hupková, M; Krcméry, V | 1 |
Frère, JM; Ledent, P | 1 |
Bello, H; Dominguez, M; Garcia, A; Gonzalez, G; Mella, S; Zemelman, R | 1 |
Abate, D; Antonacci, M; Izzo, S; Panella, S | 1 |
Spencer, RC | 1 |
Bonner, DP; Fung-Tomc, J; Kolek, B | 1 |
Greenfield, RA | 1 |
Kouda, M | 1 |
Freifeld, AG | 1 |
Hasegawa, T; Hirano, M; Imae, K; Imura, S; Kamachi, H; Kamei, H; Okita, T | 1 |
Acuña, G; Duhalde, M; Grebe, G; Labarca, J; Lira, P; Ocqueteau, M; Oliva, J; Pérez, C; Sirham, M | 1 |
Asvanich, K; Chongchitmate, A; Fugpholngam, V; Srimuang, S; Tanphaichitra, D | 1 |
Adachi, Y; Inoue, M; Kawakami, M; Matsuda, K; Nakamura, K | 1 |
Dalhoff, A; Nitsche, D; Oesser, S; Sack, M; Schulze, C | 1 |
Bujdáková, H; Kallová, J; Kettner, M; Lausová, A | 1 |
Cisterna, R; Farga, MA; Garau, J; García-de-Lomas, J; Gimeno, C; Millás, E; Navarro, D; Savall, F | 1 |
Nakagawa, Y; Toyoguchi, T | 1 |
Goto, S; Matsunaga, T; Nagashima, M; Ogawa, M; Shimohira, H; Yoshida, T | 1 |
Komoto, A; Nishino, T; Otsuki, M | 1 |
Kato, H; Kato, N; Tanaka, Y; Tanaka-Bandoh, K; Ueno, K; Watanabe, K | 1 |
Deguchi, K; Fukayama, S; Fukumoto, T; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, Y; Tanaka, S | 1 |
Choi, YJ; Hong, T; Kish, A; Millett, W; Ndamukong, J; Win, KK | 1 |
Appelbaum, PC; Jacobs, MR; Visalli, MA | 1 |
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y | 1 |
Jiang, GZ; Kato, Y; Kido, N; Koide, N; Kusumi, A; Narita, K; Sugiyama, T; Takahashi, K; Yokochi, T | 1 |
Bell-Dixon, C; Itokazu, GS; Kahan, FM; Quinn, JP; Weinstein, RA | 1 |
Bucklin, SE; Morrison, DC | 1 |
Aparicio, J; Gómez-Codina, J; Herranz, C; Llorca, C; Montalar, J; Munárriz, B; Oltra, A; Pastor, M | 1 |
Martinez-Martinez, L; Pascual, A; Perea, EJ; Rodriguez, G; Suárez, AI | 1 |
Akashi, K; Asayama, R; Gondo, H; Goto, T; Harada, N; Hayashi, S; Hisano, S; Ishikura, H; Kawasaki, C; Kozuru, M; Kumakawa, M; Morioka, E; Muta, K; Nakajima, H; Niho, Y; Nishimura, J; Okamura, T; Sawae, Y; Shibuya, T; Suehiro, Y; Suematsu, E; Uike, N; Yamasaki, K; Yamashita, S; Yufu, Y | 1 |
Matsumura, N; Minami, S; Mitsuhashi, S | 1 |
Okonogi, K; Tsuchimori, N; Yamazaki, T | 1 |
Adachi, Y; Fuse, A; Hashizume, T; Kato, E; Nagano, R; Nakagawa, S; Ohtake, N; Okamoto, O; Shibata, K | 1 |
Quentin, C; Tessier, F | 1 |
Blahová, J; Králiková, K; Krcméry, V; Kubonová, K | 1 |
Iaconis, JP; Nadler, HL; Pitkin, DH; Sheikh, W | 1 |
Hathorn, JW; Lyke, K | 1 |
Alfaro, DV; Barton, CP; Beverly, DT; Brucker, AJ; Hudson, SJ; Kasowski, EJ; King, LP; Lopez, JD | 1 |
Cabibbo, E; Corulli, M; Dima, F; Fallacara, C; Longo, M; Peroni, L; Pizzi, R; Pollara, PC; Ravizzola, G; Turano, A | 1 |
Chan, CH; Chan, TH; Ho, A; Lai, CK; Leung, R | 1 |
Buhr, HJ; Foitzik, T; Hotz, HG; Kinzig, M; Sörgel, F | 1 |
Bacci, S; Bosi, A; Fanci, R; Guidi, S; Laszlo, D; Rossi Ferrini, P; Saccardi, R; Vannucchi, AM | 1 |
Blahová, J; Hupková-Lesická, M; Králiková, K; Krcméry, V; Kubonová, K | 1 |
Klugman, KP; Koornhof, HJ | 1 |
Barthélémy, M; Hong, LT; Hornstein, M; Labia, R; Péduzzi, J; Sautjeau-Rostoker, C; Scavizzi, M; Vessières, A | 1 |
Dotters, DJ; James, AH; Katz, VL; Rogers, RG | 1 |
Hirata, Y; Igari, J; Imafuku, Y; Inoue, M; Ishigo, S; Kawaguchi, R; Kobayashi, I; Kumasaka, K; Matsuoka, K; Murakami, E; Nishino, T; Oguri, T; Ohtaki, Y; Okada, J; Okamoto, E; Saeki, H; Satou, S; Shibano, T; Takahashi, A; Tokuda, K; Uchida, K; Uehara, N; Watanabe, N; Yomoda, S; Yoshida, H | 1 |
D'Amico, DT; Ng, EW | 1 |
Giamarellos-Bourboulis, EJ; Giamarellou, H; Grecka, P | 1 |
Barie, PS; Baumgartner, TF; Dellinger, EP; Rotstein, OD; Solomkin, JS; Vogel, SB; Yang, JY | 1 |
Abe, T; Domon, H; Fukuoka, T; Harasaki, T; Hirasawa, A; Ishii, C; Iwata, M; Kakuta, M; Kawada, H; Koga, T; Kubota, M; Kuwahara, S; Masuda, N; Ohya, S; Sakagawa, E; Takenouchi, T; Utsui, Y; Yasuda, H | 1 |
Battles, A; Liu, QF; Liu, W; Louie, A; Miller, DA; Miller, MH; Sucke, AC | 1 |
Klastersky, J | 1 |
Doern, GV; Jones, RN; Pfaller, MA; Salazar, JC | 1 |
Bhutta, ZA | 1 |
Curati, W; Lynn, WA; McLaughlin, JE; Ogg, G; Peters, M; Shaunak, S | 1 |
Mulin, B; Talon, D; Thouverez, M | 1 |
Eltahawy, AT | 1 |
Ben Hassen, A; Ben Redjeb, S; Kamoun, A; Mahjoubi, F | 1 |
Aleksandrova, IA; Grudinina, SA; Rezvan, SP; Sidorenko, SV; Sterkhova, GV | 1 |
Awaya, Y; Fujiue, Y; Kodomari, Y; Kuwabara, M; Muroki, K; Shimizu, S; Watanabe, Y | 1 |
Groeneveld, PH; Kwappenberg, KM; Mattie, H; van Dissel, JT; van Langevelde, P | 1 |
Benali, K; Bingen, E; Bonacorsi, S; Doit, C; Fitoussi, F; Geslin, P | 1 |
Alcaide, F; Carratalà, J; Fernández-Sevilla, A; Gudiol, F; Rosón, B | 1 |
Hasegawa, Y; Imai, C; Nakae, M; Osaka, K; Sasaki, H; Shibasaki, K; Sugahara, Y; Yasui, H | 1 |
Dionyssiou-Asteriou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Grecka, P | 1 |
Bartoníková, N; Blahová, J; Hupková-Lesická, M; Králiková, K; Krcméry, V; Kubonová, K; Schäfer, V; Torsová, V | 1 |
Fukuhara, J; Furuhata, N; Ikeda, A; Kimura, F; Kouda, M; Maruyama, M; Matsuzaki, H; Nomura, H; Ohgawara, M; Ono, E; Sasaki, K; Satoh, H; Sawabe, E; Suzuki, T; Takahashi, I; Takeuchi, M; Tohi, H | 1 |
Gabriel, V; Garbino, J; Harbarth, S; Lew, D; Pittet, D | 1 |
Burns, JM; Dominick, D; Freeman, K; Horn, D; Lim, M; Mariano, N; Marks, S; Maurer, J; Rahal, JJ; Segal-Maurer, S; Urban, C | 1 |
Ahmed, A; Ahmed, QT; Hafiz, S; Majeed, H; Syed, S | 1 |
Biron, P; Cure, H; Fuhrmann, C; Grès, JJ; Lefebvre, D; Rollin, C; Soler-Michel, P; Thyss, A; Viens, P; Viot, M | 1 |
Ho, SW; Hsueh, PR; Jan, IS; Luh, KT; Teng, LJ | 1 |
Hidri, N; Jacolot, A; Leotard, S; Mimoz, O; Nordmann, P; Petitjean, O; Samii, K | 1 |
Kinoshita, S; Kumagai, S | 1 |
Fujita, N; Kitaura, K; Oka, T; Satoh, S; Sohma, A; Toda, S; Wada, Y; Yamagishi, H | 1 |
Arbo, MD; Barefoot, L; Hariharan, R; Nathan, C; Snydman, DR; Weinstein, RA | 1 |
Black, DJ; Deliganis, S; Duchin, JS; Frick, PA; Fritsche, TR; McKee, WM | 1 |
Lawrence, C; Nauciel, C; Ronco, E | 1 |
Akiyama, H; Arata, J; Kanzaki, H; Tada, J; Yamasaki, O | 1 |
Blondeau, JM; Borsos, S; Misfeldt, C; Suter, ME | 1 |
Hamilton-Miller, JM; Shah, S | 1 |
Berger, D; Heinemann, M; Möricke, A; Seidelmann, M; Trautmann, M; Zick, R | 1 |
Borja, J; Herreras, A | 1 |
Sato, S; Toriya, M; Tsuji, A; Yamaguchi, S | 1 |
Andrzejewska, E; Kaniasty, M; Szkaradkiewicz, A | 1 |
Ballow, CH; Forrest, A; Highet, VS; Schentag, JJ | 1 |
Chan, WC; Cheng, AF; Li, RC; Ling, JM; Schentag, JJ | 1 |
Gildon, KM; Norrby, SR | 1 |
Hikida, M; Igarashi, A; Itahashi, K; Kitamura, M; Shiba, T | 1 |
Elhelali, N; Jacolot, A; Laurent, F; Léotard, S; Mimoz, O; Nordmann, P; Petitjean, O; Samii, K | 1 |
Berger, D; Heinemann, M; Lorenz, I; Möricke, A; Schneider, M; Seidelmann, M; Steinbach, G; Trautmann, M | 1 |
Allerberger, F; Feierl, G; Hirschl, A; Krause, R; Mittermayer, H; Reisinger, EC; Wendelin, I | 1 |
Angus, BJ; Chaowagul, W; Howe, PA; Rajanuwong, A; Simpson, AJ; Smith, MD; Suputtamongkol, Y; Walsh, AL; White, NJ; Wuthiekanun, V | 1 |
Arita, K; Daido, K; Kohara, T; Nakamura, K; Ohashi, N; Takeshima, Y | 1 |
Chaowagul, W; Kurimoto, M; Lauw, FN; Prins, JM; Simpson, AJ; Smith, MD; Speelman, P; van der Poll, T; van Deventer, SJ; White, NJ | 1 |
Cho, JH; Jin, C; Jung, I; Kim, DH; Kim, M; Ku, HJ; Oh, CH; Yook, J | 1 |
Deblangy, C; Decré, D; Fichelle, A; Joly-Guillou, ML; Kosmann, MJ; Lucet, JC; Pernet, M; Régnier, B | 1 |
Kays, MB | 1 |
Iyobe, S; Kobayashi, I; Okubo, T; Takahashi, A; Tsunoda, M; Yomoda, S | 1 |
Angus, BJ; Chaowagul, W; Prins, JM; Simpson, AJ; Smith, MD; Suputtamongkol, Y; van Deventer, SJ; Weverling, GJ; White, NJ | 1 |
Fujimura, S; Gomi, K; Honda, Y; Kikuchi, T; Kobayashi, T; Nukiwa, T; Shoji, S; Takahashi, H; Tokue, Y; Watanabe, A; Yasui, S | 1 |
Deguchi, K; Endo, H; Ishihara, R; Matsumoto, Y; Nishinari, C; Suzuki, Y | 1 |
Bollet, C; Bornet, C; Bosi, C; Davin-Regli, A; Pages, JM | 1 |
Burgos, A; Campillos, P; Gonzalo, N; López-Lozano, JM; Monnet, DL; Saez, M; Yagüe, A | 1 |
Jacolot, A; Leotard, S; Louchahi, K; Mimoz, O; Nordmann, P; Padoin, C; Petitjean, O | 1 |
Horn, DL; Morrison, DC; Norimatsu, M; Silverstein, R; Wood, JG; Xue, Q | 1 |
Norrby, SR | 1 |
Fukuhara, J; Homma, S; Kouda, M; Takeuchi, M; Tamura, K; Udagawa, I | 1 |
Christenson, JC; Daly, JA; Korgenski, EK | 1 |
Ballesta, S; Benedí, VJ; Conejo, MC; Hernández-Allés, S; Martínez-Martínez, L; Pascual, A; Perea, EJ; Ramírez De Arellano-Ramos, E | 1 |
Lumbiganon, P; Panamonta, O | 1 |
Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
Inoue, M; Matsuda, K | 1 |
Anderlik, P; Filetóth, Z; Máthé, A; Rókusz, L; Rozgonyi, F; Szabó, D | 1 |
Becerril, B; Caballero-Granado, FJ; Cisneros, JM; Cuberos, L; Moreno, I; Pachón, J | 1 |
Barry, AL; Brown, SD; Fuchs, PC | 1 |
Chong, Y; Jang, SJ; Lee, HS; Lee, K; Lee, MH; Park, AJ; Song, WK | 1 |
Abe, T; Fukuoka, T; Inoue, H; Ohya, S | 1 |
Carmeli, Y; Harbarth, S; Harris, AD; Samore, MH | 1 |
Endo, H; Jinbo, K; Nishinari, C; Suzuki, Y; Tamura, C | 1 |
Anthony, L; Appelbaum, PC; Credito, K; Ednie, LM; Hoellman, DB; Jacobs, MR; Kelly, LM | 1 |
Higashiyama, Y; Hirakata, Y; Kadota, JI; Kakeya, H; Kaneko, Y; Kohno, S; Kuroki, M; Miyazaki, Y; Ohi, H; Tomono, K; Yanagihara, K | 1 |
Chen, M; Xu, Y; Zhang, S | 1 |
Chen, M; Liu, J; Wang, C; Wang, H; Wang, P; Xie, X; Xu, Y; Yuan, Y; Zhang, X; Zhang, Y | 1 |
Blandino, G; Caccamo, F; Milazzo, I; Musumeci, R; Nicoletti, G; Speciale, A | 1 |
Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E | 1 |
Badolati, A; Fontán, PA; Gammella, D; Maskin, B; Spinedi, EG | 1 |
Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 2 |
Araake, M; Gotoh, N; Hiraishi, T; Miyata, A; Nishino, T; Ogawa, H; Takata, T | 1 |
Karp, MT; Kurittu, JS; Valtonen, SJ | 1 |
Jones, RN; Mutnick, AH; Turner, PJ | 1 |
Furugo, I; Ishida, M; Takii, M; Ueda, M | 1 |
Han, C; Jin, Y; Zhang, R | 1 |
Flores, C; Goldani, LZ; Hadlich, E; Maguilnik, I | 1 |
Blanco, G; de Mier, C; Famiglietti, A; Juárez, J; Pugliese, L; Rodríguez, CH; Vay, C | 1 |
Burgmann, H | 1 |
Beketov, AS; Komarov, RM; Pisarev, VV; Sidorenko, SV | 1 |
Afif, C; Boktour, MR; Escalante, C; Hachem, RY; Hanna, HA; Husni, R; Jacobson, K; Kantarjian, H; Kontoyiannis, D; Levett, LM; Raad, II; Rolston, KV; Whimbey, EE | 1 |
Choi, TY; Chong, YS; Kang, JO; Kang, SH; Kim, EC; Kim, MY; Lee, KW | 1 |
Kadry, AA | 1 |
Aymon, D; Bally, F; Bille, J; Chiolero, R; Cometta, A; Garbino, J; Glauser, MP; Greub, G; Kinge, T; Krawczyk, L; Lew, D; Romand, JA; Rubinstein, E; Schaller, MD; Stratchounski, L; Zanetti, G | 1 |
Hashimoto, K; Ito, K; Ogata, H | 1 |
Choi, SH; Chung, JW; Hyong Kim, T; Kim, NJ; Kim, YS; Lee, SO; Ryu, J; Woo, JH | 1 |
Chong, Y; Hong, SG; Jang, SJ; Kim, M; Lee, HJ; Lee, K; Ryoo, N | 1 |
Hoshinaga, K; Ishikawa, K; Miyakawa, S; Naide, Y; Shiroki, R; Tanaka, T | 1 |
Bollet, C; Bornet, C; Davin-Régli, A; Pagès, JM; Thiolas, A | 1 |
Aoki, S; Gotoh, N; Hirakata, Y; Kamihira, S; Kohno, S; Kondoh, A; Miyazaki, Y; Tomono, K; Yamada, Y; Yanagihara, K | 1 |
Chuang, CL; Tsai, SH; Wu, JJ; Yan, JJ | 1 |
Lee, WS; Lin, ML; Liu, CY; Wang, FD | 1 |
Bugnon, D; Caillon, J; Gras-Le Guen, C; Jacqueline, C; Kergueris, MF; Navas, D; Potel, G | 1 |
Cefalo, G; Massimino, M; Mazza, E; Scaramuzza, D; Spreafico, F | 1 |
Björkholm, M; Cherif, H; Engervall, P; Hast, R; Johansson, P; Kalin, M; Ljungman, P | 1 |
Bernabéu-Wittel, M; de Cueto, M; del Carmen Conejo, M; García, I; Jiménez-Mejías, ME; Martínez-Martínez, L; Pachón, J; Pachón-Ibáñez, ME; Pascual, A; Pichardo, C | 1 |
Barie, PS; Dellinger, EP; Grasela, TH; Rotstein, OD; Walawander, CA | 1 |
Arnal, JM; Berger, P; Franceschini, B; Gainnier, M; Michel, F; Papazian, L; Sainty, JM | 1 |
Avilova, ND; Gordeev, IuN; Mitrokhin, SD; Sokolov, AA; Zabaznyĭ, NP | 1 |
Benbachir, M; Benchekroun, S; Harif, M; Loukili, A; Mahmal, L; Quessar, A | 1 |
Conejo, C; Ibáñez-Martínez, J; Martínez-Martínez, L; Pachón, J; Pachón-Ibañez, ME; Pascual, A; Pichardo, C; Rodríguez-Martínez, JM | 1 |
Kuti, JL; Nicolau, DP; Sun, HK | 1 |
Batard, E; Caillon, J; Kergueris, MF; Le Conte, P; Moreau, P; Navas, D; Potel, G | 1 |
Albertí, S; Alonso, D; Borrell, N; Doménech-Sánchez, A; Gomez, C; Padilla, E; Pérez, JL | 1 |
Cheng, KC; Chuang, YC; Huang, GC; Wu, LT; Yu, WL | 1 |
Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H | 1 |
Li, C; Nicolau, DP; Nightingale, CH; Ong, CT; Tessier, PR | 1 |
Konkoly-Thege, M; Kuti, JL; Ludwig, E; Nicolau, DP | 1 |
Bokaei, S; Etemadi, G; Feizabadi, MM; Rahmati, M; Shabanpoor, S; Yadegarinia, D | 1 |
Alp, E; Aygen, B; Metan, G; Sumerkan, B | 1 |
Elsa, V; María, A; Nieves, B; Ruíz, J; Ruiz, M; Salazar De Vegas, EZ; Vila, J | 1 |
Caviezel, A; Garbino, J; Lew, D; Matulionyte, R; Morel, P; Uckay, I; Villiger, P | 1 |
Chen, YS; Chiu, CJ; Chu, C; Lee, CH; Liu, JW; Su, LH | 1 |
Mammeri, H; Nordmann, P; Poirel, L | 1 |
Hoda, MQ; Hussein, K; Manasia, R; Salahuddin, N; Samad, A; Siddiqui, S; Zafar, A | 1 |
Bertoluci, DF; Dell'Aquilla, AM; López, KJ; Santos, SR; Vicente, KM | 1 |
Guo, ZL; He, LX; He, ZG; Liang, YJ; Ren, T; Zhai, XB; Zhang, L; Zheng, YH | 1 |
Cha, R | 1 |
Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ | 1 |
Berkani, A; Eb, F; Mammeri, H; Nordmann, P | 1 |
Appelbaum, PC; Glupczynski, Y; Lemaire, S; Olivier, A; Tulkens, PM; Van Bambeke, F | 1 |
Daimon, Y; Tanaka, K; Watanabe, K | 1 |
Edmond, M; Harpe, SE; Johnson, C; Pakyz, A; Polk, RE; Powell, JP | 1 |
Ben Redjeb, S; Mbarek, M; Meddeb, B; Messadi, Aa; Thabet, L; Turki, A | 1 |
Ascerić, M; Custović, A; Hadzić, S; Zulcić-Nakić, V | 1 |
Choe, KW; Jeon, JH; Kim, HB; Kim, NJ; Lee, HS; Oh, MD; Park, SW; Park, WB; Song, KH | 1 |
Bou, G; Torres, E; Villanueva, R | 1 |
Arlet, G; Bakour, R; Dallenne, C; Geneste, D; Iabadene, H; Messai, Y | 1 |
Conejo, Mdel C; Hernández, JR; Pascual, A | 1 |
Arnold, HM; Augustin, KM; Casabar, E; Dubberke, ER; Hladnik, LM; McKinnon, PS; Reichley, RM; Ritchie, DJ; Westervelt, P | 1 |
Faccone, D; Galas, M; López, Y; Maggi, G; Marcano, D; Pasterán, F; Payares, D; Rapoport, M; Salgado, N; Sánchez, D; Spadola, E; Ugarte, C | 1 |
Albertí, S; Juan, C; Mulet, X; Oliver, A; Pérez, JL; Zamorano, L | 1 |
Lee, HJ; Lee, KM; Suh, JT; Yang, HY | 1 |
Ge, Y; Juan, C; Moyá, B; Oliver, A; Zamorano, L | 1 |
Aguilar, L; Alou, L; Cafini, F; Coronel, P; Giménez, MJ; González, N; Prieto, J; Sevillano, D; Torrico, M | 1 |
Araj, GF; Awar, GN; Baban, TA; Kanj, SS; Naba, MR; Tabbarah, ZA | 1 |
Jacobus, NV; McDermott, LA; Snydman, DR | 1 |
Bivas, A; Fraser, A; Leibovici, L; Paul, M; Yahav, D | 1 |
Chumjan, W; Hajjar, E; Mahendran, KR; Schulte, A; Suginta, W; Weingart, H; Winterhalter, M | 1 |
Bebrone, C; Docquier, JD; Favier, A; Ferrer, JL; Frère, JM; Galleni, M; Lassaux, P; Laurent, C; Loisel, E; Sohier, JS; Traoré, DA | 1 |
Kochhar, R; Noor, MT; Radhakrishna, Y; Ray, P; Singh, K; Sinha, SK; Wig, JD | 1 |
Appelbaum, PC; Armstrong, ES; Kosowska-Shick, K; Kubo, A; Lin, G; Pankuch, GA | 1 |
Cabot, G; Macia, MD; Martínez-Martínez, L; Moya, B; Ocampo-Sosa, AA; Oliver, A; Peña, C; Rodríguez, C; Suárez, C; Tubau, F; Zamorano, L | 1 |
Altunsoy, A; Aypak, C; Azap, A; Balık, I; Ergönül, Ö | 1 |
Gonçalves-Pereira, J; Póvoa, P | 1 |
Tuğrul, HM; Yıldırım, MI | 1 |
Kan, Y; Kartal, M; Orhan, IE; Ozcelik, B | 1 |
Aracil, B; Beceiro, A; Bou, G; Cercenado, E; Fernández, A; Kerff, F; Miro, E; Navarro, F; Oliver, A; Oteo, J; Pérez-Llarena, FJ; Zamorano, L | 1 |
Alberti, S; Beceiro, A; Cabot, G; Juan, C; Moyá, B; Oliver, A; Zamorano, L | 1 |
Fu, W; Lin, Z; Liu, Z; Zhang, B; Zhang, X | 1 |
Bogomolova, NS; Bol'shakov, LV; Kuznetsova, SM; Parshin, VD; Vishnevskaia, GA | 1 |
Mondal, A; Rajamohan, G; Srinivasan, VB; Vaidyanathan, V; Venkataramaiah, M | 1 |
Chang, HL; Chang, HY; Chang, YF; Chi, CY; Ho, CM; Ho, MW; Lai, CH; Lin, CD; Lin, CW; Lin, HH; Lu, JJ; Teng, LJ; Tien, N; Tseng, SP | 1 |
Al-Agamy, MH | 1 |
Goff, DA; Nicolau, DP | 1 |
Chlebicki, MP; Kwa, AL; Lee, AL; Lee, W; Liew, LT; Lim, CL; Nah, SC; Wan, CN | 1 |
Chen, Z; Kang, M; Li, D; Tao, C; Wang, T; Xie, Y | 1 |
Bruchmann, S; Cabot, G; Haussler, S; Juan, C; Moyà, B; Mulet, X; Oliver, A; Zamorano, L | 1 |
Hayakawa, K; Kirikae, T; Kubota, S; Kuroda, E; Kutsuna, S; Mezaki, K; Miyoshi-Akiyama, T; Nagamatsu, M; Ohmagari, N; Shimada, K; Sugiki, Y; Takeshita, N; Tojo, M | 1 |
Boutoille, D; Bretonnière, C; Caillon, J; Desessard, C; Guitton, C; Jacqueline, C; Potel, G | 1 |
de la Torre, J; Del Arco, A; Faus, V; Fernández, F; García-Alegría, J; Montiel, N; Olalla, J; Prada, JL; Rivas, F; Tortajada, B | 1 |
Gu, B; Mei, Y; Wen, Y; Xia, W; Zhang, X | 1 |
Akiyama, N; Fukushima, T; Hatanaka, K; Hino, M; Kanamaru, A; Masaoka, T; Nakagawa, Y; Nakane, T; Ohyashiki, K; Takahashi, T; Tamaki, T; Tamura, K; Tanimoto, M; Tatsumi, Y; Urabe, A; Yoshida, I | 1 |
Appalla, L; Koren, M; Kwak, YI; Lesho, EP; McGann, P; Ong, AC; Snesrud, E; Waterman, PE | 1 |
Chia, JH; Hsu, PC; Kuo, AJ; Lee, CH; Lee, MH; Su, TY; Ye, JJ | 1 |
Gentry, CA; Williams, RJ | 1 |
Rüegg, S; Sutter, R; Tschudin-Sutter, S | 1 |
Bhadoria, AS; Jindal, A; Kumar, M; Maiwall, R; Sarin, SK | 1 |
Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F | 1 |
Srinivas, NR | 1 |
Brasca, M; Decimo, M; Silvetti, T | 1 |
Calfee, DP; Eiras, DP; Furuya, EY; Gomez-Simmonds, A; Jenkins, SG; Kubin, CJ; Loo, A; Nelson, B; Satlin, MJ; Whittier, S | 1 |
Chen, TL; Chuang, MF; Huang, WC; Kuo, SC; Lauderdale, TL; Lee, Y; Tseng, KC; Yang, YS | 1 |
Aracil-García, B; Campos, J; Cuevas-Lobato, Ó; Fernández-Romero, S; Lara-Fuella, N; Oteo-Iglesias, J; Pérez-Grajera, I; Pérez-Vázquez, M | 1 |
Ardebili, A; Azimi, L; Bijari, A; Fallah, F; Lari, AR; Lari, ER | 1 |
Chen, J; Kong, C; Zhang, Y; Zhu, L; Zou, X | 1 |
Lee, DG; Lee, SH; Lee, Y; Yoo, KH | 1 |
Hackel, MA; Hoban, DJ; Karlowsky, JA; Lob, SH; Sahm, DF | 1 |
Lavigne, JP; Meiller, E; Merens, A; Nicolas-Chanoine, MH; Pantel, A; Robert, J | 1 |
Gao, L; Li, Y; Lyu, Y | 1 |
D'Arcy, S; Doumith, M; Findlay, J; Hopkins, KL; Howe, R; Mather, B; Meunier, D; Mustafa, N; Pike, R; Woodford, N; Wootton, M | 1 |
Ambretti, S; Campoli, C; Gaibani, P; Giannella, M; Landini, MP; Lewis, RE; Re, MC; Viale, P; Volpe, SL | 1 |
Keller, PM; Müller, DM; Rominski, A; Sander, P; Schulthess, B | 1 |
Badal, R; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
Feng, H; Fleming, J; Liu, W; Liu, X; Wang, DC; Wang, S | 1 |
Alvarez, DN; Bayer, AS; Farah, S; Garcia-de-la-Maria, C; Miro, JM; Mishra, NN; Sakoulas, G; Zapata, B | 1 |
Avril, C; Belmonte, O; Benoit-Cattin, T; Bertrand, X; Bonnin, RA; Cholley, P; de Montera, AM; Dortet, L; Filleul, L; Hocquet, D; Jaffar-Bandjee, MC; Leclaire, A; Lugagne, N; Martak, D; Miltgen, G; Naas, T; Roquebert, B; Subiros, M; Thouverez, M; Traversier, N | 1 |
Hao, D; Hu, Z; Liu, X; Sun, T; Tian, H; Wang, T; Wang, X | 1 |
Ishibashi, N; Ito, A; Ito-Horiyama, T; Nishikawa, T; Ota, M; Sato, T; Tsuji, M; Yamano, Y | 1 |
Ejaz, A; Ejaz, H; Javed, H; Saleem, R; Younas, S; Zafar, A | 1 |
Hsueh, PR; Hsueh, SC; Huang, YT; Lee, YJ; Liao, CH; Tsuji, M | 1 |
Hu, L; Palzkill, T; Prasad, BVV; Sankaran, B; Sun, Z | 1 |
Goudarzi, G; Shakib, P | 1 |
Cox, JAG; Desai, M; Harrison, J; Lambert, PA; Lopeman, RC; Rathbone, DL | 1 |
Cabot, G; Fernández-Esgueva, M; Fraile-Ribot, PA; Huarte, R; López-Calleja, AI; Mulet, X; Oliver, A; Rezusta, A | 1 |
DePestel, DD; Karlowsky, JA; Lob, SH; Motyl, MR; Raddatz, J; Sahm, DF; Young, K | 1 |
Al-Hasan, MN | 1 |
Gatermann, SG; Körber-Irrgang, B; Korte-Berwanger, M; Kresken, M; Pfennigwerth, N; Seifert, H | 1 |
Canovas, J; Chau, F; Fantin, B; Le Monnier, A; Lefort, A; Petitjean, G | 1 |
Bassetti, M; Battaglini, D; Giacobbe, DR; Pelosi, P; Vena, A | 1 |
Bragantini, D; Carrara, E; Cattaneo, P; Chiamenti, M; Ellis, S; Franceschi, F; Giske, CG; Lodise, T; Menchinelli, G; Piddock, LJV; Righi, E; Sanguinetti, M; Savoldi, A; Scudeller, L; Tacconelli, E | 1 |
Clabots, C; Johnson, JR; Johnston, BD; Porter, SB; Thuras, P | 1 |
Carvalhaes, CG; Castanheira, M; Sader, HS; Shortridge, D | 1 |
Castanheira, M; Duncan, LR; Mendes, RE; Sader, HS | 1 |
Arend, LNVS; Bail, L; Ito, CAS; Nogueira, KDS; Tuon, FF | 1 |
Cabot, G; Gomis-Font, MA; Juan, C; López-Argüello, S; Moyá, B; Oliver, A; Zamorano, L | 1 |
DeRyke, CA; Hilbert, DW; Karlowsky, JA; Lob, SH; Motyl, MR; Sahm, DF; Siddiqui, F; Wong, MT; Young, K | 1 |
Batchelder, HR; Lamichhane, G; Nuermberger, EL; Panthi, CM; Rimal, B; Story-Roller, E; Tabor, C; Townsend, CA | 1 |
Amadesi, S; Ambretti, S; Gaibani, P; Lazzarotto, T | 1 |
Alonso-García, I; Arca-Suárez, J; Beceiro, A; Bou, G; Cabot, G; Fraile-Ribot, PA; Galán-Sánchez, F; Guijarro-Sánchez, P; Lasarte-Monterrubio, C; Oliver, A; Rumbo-Feal, S; Vázquez-Ucha, JC | 1 |
Wang, Y; Zhang, W | 1 |
Findlay, J; Nordmann, P; Poirel, L; Rens, C | 1 |
Cheng, B; Guo, P; Jia, P; Xu, Y; Yang, Q; Zhang, H; Zhu, Y | 1 |
Haines, RR; Hammer, KA; Putsathit, P; Tai, AS | 1 |
Bandić-Pavlović, D; Barišić, I; Beader, N; Bedenić, B; Frančula-Zaninović, S; Krilanović, M; Pešorda, L; Schoenthaler, S; Veir, Z | 1 |
Abdulhemid Said, L; Muhsin, EA; Sajid Al-Jubori, S | 1 |
Kollef, MH; Windham, S | 1 |
Alekseeva, I; DeRyke, CA; Hawser, SP; Lob, SH; Motyl, MR; Sahm, DF; Siddiqui, F; Young, K | 1 |
Cabot, G; Khajehpour, M; Kim, K; Mark, BL; Oliver, A | 1 |
Arends, SJR; Carvalhaes, CG; Castanheira, M; Mendes, RE; Sader, HS; Shortridge, D | 1 |
Aja-Macaya, P; Alonso-García, I; Arca-Suárez, J; Beceiro, A; Bou, G; Fernández-González, A; Galán-Sánchez, F; González-Mayo, E; Guijarro-Sánchez, P; Lada-Salvador, P; Lasarte-Monterrubio, C; Martínez-Guitián, M; Muíño-Andrade, M; Oliver, A; Rodríguez-Iglesias, M; Rumbo-Feal, S; Vázquez-Ucha, JC; Vela-Fernández, R | 1 |
Hsueh, PR; Ko, WC; Lee, YL | 1 |
22 review(s) available for cephalosporin c and imipenem, anhydrous
Article | Year |
---|---|
[New cephalosporins and imipenem].
Topics: Bacterial Infections; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; In Vitro Techniques | 1991 |
Susceptibility testing of anaerobic bacteria.
Topics: Agar; Anti-Bacterial Agents; Bacteria, Anaerobic; Cephalosporins; Culture Media; Drug Resistance, Microbial; Imipenem; Microbial Sensitivity Tests; Quality Control | 1989 |
Antimicrobial agents in pediatrics.
Topics: Adolescent; Adult; Age Factors; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Child; Child, Preschool; Cilastatin; Cystic Fibrosis; Humans; Imipenem; Infant; Tissue Distribution | 1989 |
Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Glycopeptides; Imipenem; Methicillin; Norfloxacin; Oxacillin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Thienamycins; Vancomycin | 1986 |
Immediate hypersensitivity reactions to beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Hypersensitivity, Immediate; Imipenem; Penicillins; Skin Tests; Thienamycins | 1987 |
New antibiotics: areas of appropriate use.
Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Infections; beta-Lactamase Inhibitors; Cephalosporins; Ciprofloxacin; Enoxacin; Humans; Imipenem; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Thienamycins | 1987 |
Antimicrobial therapy of bacterial sepsis in the newborn infant.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Aztreonam; Bacteria; Cephalosporins; Cross Infection; Drug Therapy, Combination; Humans; Imipenem; Infant Mortality; Infant, Newborn; Penicillin Resistance; Penicillins; Sepsis; Thienamycins | 1985 |
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefmenoxime; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Moxalactam | 1982 |
The newer cephalosporins. Aztreonam and imipenem.
Topics: Aztreonam; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Monobactams; Thienamycins | 1995 |
Clinical pharmacokinetics during continuous haemofiltration.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Half-Life; Hemofiltration; Humans; Imipenem; Metabolic Clearance Rate; Pharmacokinetics; Protein Binding; Tissue Distribution; Ultrafiltration; Vancomycin | 1994 |
Symposium on antimicrobial therapy. V. The carbapenems and monobactams.
Topics: Aztreonam; Bacterial Infections; Cephalosporins; Humans; Imipenem; Microbial Sensitivity Tests | 1993 |
Infectious complications in the immunocompromised host. The antimicrobial armamentarium.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antiprotozoal Agents; Azoles; Aztreonam; Cephalosporins; Fluoroquinolones; Foscarnet; Ganciclovir; Humans; Imipenem; Immunocompromised Host; Infections; Neoplasms; Pneumonia, Pneumocystis; Vancomycin | 1993 |
Empirical treatment of febrile neutropenia: evolution of current therapeutic approaches.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; Humans; Imipenem; Meropenem; Neutropenia; Thienamycins | 1997 |
[Febrile neutropenia: empiric antibiotic therapy from 1975 to 1997].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Meropenem; Neutropenia; Sepsis; Thienamycins | 1997 |
Safety profile of meropenem: a review of nearly 5,000 patients treated with meropenem.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Clindamycin; Diarrhea; Drug Eruptions; Humans; Imipenem; Meningitis; Meropenem; Nausea; Seizures; Thienamycins; Thrombocytosis | 1999 |
Carbapenems in serious infections: a risk-benefit assessment.
Topics: Adult; Cephalosporins; Child; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Tolerance; Humans; Imipenem; Meningitis, Bacterial; Meropenem; Risk Assessment; Seizures; Thienamycins | 2000 |
Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Fever; Humans; Imipenem; Meropenem; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Thienamycins | 2010 |
Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Cefpirome; Ceftazidime; Cephalosporins; Critical Illness; Humans; Imipenem; Infections; Meropenem; Piperacillin; Thienamycins | 2011 |
Seizures as adverse events of antibiotic drugs: A systematic review.
Topics: Animals; Anti-Bacterial Agents; Central Nervous System; Cephalosporins; Humans; Imipenem; Risk; Seizures | 2015 |
The role of new antimicrobials for Gram-negative infections in daily clinical practice.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactams; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Polymyxins; Sisomicin; Tazobactam; Tetracyclines | 2020 |
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.
Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Polymyxins; Rifampin; Tazobactam; Tobramycin | 2021 |
How to use new antibiotics in the therapy of serious multidrug resistant Gram-negative infections?
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem | 2022 |
22 trial(s) available for cephalosporin c and imipenem, anhydrous
Article | Year |
---|---|
Adjunctive antimicrobials in surgery of soft tissue infections: evaluation of cephalosporins and carbapenems.
Topics: Adult; Aged; Bacterial Infections; Carbapenems; Cefmetazole; Cefoperazone; Cefotetan; Cefoxitin; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Remission Induction; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections; Thienamycins | 1991 |
[Short-term antibiotic prophylaxis in surgery].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cephalosporins; Child; Cilastatin; Drug Combinations; Drug Evaluation; Female; Humans; Imipenem; Male; Middle Aged; Postoperative Period; Preoperative Care; Surgical Wound Infection | 1993 |
[Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Chi-Square Distribution; Cilastatin; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infections; Male; Middle Aged; Neutropenia; Prognosis; Prospective Studies; Protease Inhibitors; Thienamycins | 1995 |
Randomised comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Opportunistic Infections; Prospective Studies; Thienamycins | 1996 |
[Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Imipenem; Immunocompromised Host; Male; Middle Aged; Opportunistic Infections; Penicillins | 1996 |
Hospitalized patients with community-acquired pneumonia in Hong Kong: a randomized study comparing imipenem/cilastatin and ceftazidime.
Topics: Adult; Aged; Ceftazidime; Cephalosporins; Cilastatin; Community-Acquired Infections; Drug Therapy, Combination; Female; Follow-Up Studies; Hong Kong; Hospitalization; Humans; Imipenem; Injections, Intravenous; Male; Pneumonia, Bacterial; Protease Inhibitors; Survival Rate; Thienamycins | 1997 |
Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipients.
Topics: Adolescent; Adult; Bacteria; Bacterial Infections; Bone Marrow Transplantation; Ceftazidime; Cephalosporins; Child; Cilastatin; Drug Synergism; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Imipenem; Male; Middle Aged; Netilmicin; Neutropenia; Postoperative Complications; Protease Inhibitors; Thienamycins; Treatment Outcome | 1997 |
A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group.
Topics: Abdomen; Abdominal Abscess; Adult; Aged; Antitrichomonal Agents; Appendicitis; Cefepime; Cephalosporins; Cilastatin; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Imipenem; Infections; Male; Metronidazole; Middle Aged; Peritonitis; Treatment Outcome | 1997 |
Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella.
Topics: Adult; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Utilization Review; Guideline Adherence; Hospital Bed Capacity, 500 and over; Hospitals, Community; Humans; Imipenem; Incidence; Infection Control; Klebsiella; Klebsiella Infections; New York City; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1998 |
Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer).
Topics: Antineoplastic Agents; Cefepime; Cephalosporins; Cilastatin; Drug Therapy, Combination; Fever; Humans; Imipenem; Neoplasms; Neutropenia; Risk Factors; Survival Analysis | 1998 |
[Effects of prophylactic antibiotic agent on interleukin-6 level in open chest surgery--comparison between imipenem and flomoxef].
Topics: Adult; Aged; Antibiotic Prophylaxis; Bacterial Infections; Cephalosporins; Humans; Imipenem; Interleukin-6; Middle Aged; Postoperative Complications; Postoperative Period; Thienamycins; Thoracic Surgical Procedures | 1998 |
Comparison of imipenem and ceftazidime as therapy for severe melioidosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ceftazidime; Cephalosporins; Female; Humans; Imipenem; Male; Melioidosis; Middle Aged; Prospective Studies; Thienamycins; Treatment Failure; Treatment Outcome | 1999 |
Elevated plasma concentrations of interferon (IFN)-gamma and the IFN-gamma-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Burkholderia pseudomallei; Ceftazidime; Cephalosporins; Female; Humans; Imipenem; Interferon-gamma; Interleukin-12; Interleukin-15; Interleukin-18; Interleukins; Male; Melioidosis; Middle Aged; Thienamycins | 1999 |
Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; APACHE; Bacteremia; Biomarkers; Burkholderia pseudomallei; Ceftazidime; Cephalosporins; Cytokines; Female; Humans; Imipenem; Interleukin-10; Interleukin-6; Lactates; Logistic Models; Male; Melioidosis; Middle Aged; Prognosis; Thienamycins; Tumor Necrosis Factor-alpha | 2000 |
Evaluation of endotoxin release and cytokine production induced by antibiotics in patients with Gram-negative nosocomial pneumonia.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cross Infection; Cytokines; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-1; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Sepsis; Statistics, Nonparametric; Thienamycins; Tumor Necrosis Factor-alpha | 2002 |
[Comparative clinical and epidemiological evaluation of beta-lactam antibiotics in the treatment of intraabdominal infections].
Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cefoperazone; Cephalosporins; Clinical Trials as Topic; Costs and Cost Analysis; Drug Combinations; Humans; Imipenem; Meropenem; Models, Economic; Sulbactam; Thienamycins | 2003 |
Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Cefepime; Cephalosporins; Female; Fever; Hospitalization; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Vancomycin | 2003 |
Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study.
Topics: Adult; Aged; APACHE; Cefepime; Cephalosporins; Cilastatin; Critical Care; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Endpoint Determination; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia, Pneumococcal; Prospective Studies; Protease Inhibitors; Respiration, Artificial; Thienamycins | 2003 |
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Fever; Follow-Up Studies; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Probability; Prospective Studies; Risk Assessment; Single-Blind Method; Survival Analysis; Sweden; Treatment Outcome | 2004 |
A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
Topics: Abdominal Cavity; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacterial Infections; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Hospitals, University; Humans; Imipenem; Male; Metronidazole; Middle Aged | 2007 |
Cefozopran, meropenem, or imipenem-cilastatin compared with cefepime as empirical therapy in febrile neutropenic adult patients: A multicenter prospective randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cefozopran; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Thienamycins; Young Adult | 2015 |
A randomized open label study of 'imipenem vs. cefepime' in spontaneous bacterial peritonitis.
Topics: Adult; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Cefepime; Cephalosporins; Cross Infection; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Imipenem; India; Liver Cirrhosis; Male; Middle Aged; Paracentesis; Peritonitis; Risk Factors; Severity of Illness Index; Survival Analysis; Time Factors | 2016 |
362 other study(ies) available for cephalosporin c and imipenem, anhydrous
Article | Year |
---|---|
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity | 2007 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Pharmacodynamic effects of antibiotics. Studies on bacterial morphology, initial killing, postantibiotic effect and effective regrowth time.
Topics: Amdinocillin; Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Daptomycin; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Peptides; Piperacillin; Vancomycin | 1992 |
[Sensitivity of multiresistant bacterial strains to imipenem (Tienam)].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Infant, Newborn; Microbial Sensitivity Tests | 1992 |
Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem, and ciprofloxacin.
Topics: Adult; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Ciprofloxacin; Half-Life; Humans; Imipenem; Male; Microbial Sensitivity Tests | 1992 |
[Evolution of the bacteria responsible for surgical infection. n 8-year study in our department].
Topics: Amikacin; Ampicillin Resistance; Bacteria; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Imipenem; Penicillin Resistance; Surgical Procedures, Operative; Time Factors | 1992 |
Bactericidal activity of cefclidin (E1040) against Pseudomonas aeruginosa under conditions simulating plasma pharmacokinetics: lack of development of chromosomally-mediated resistance to beta-lactams.
Topics: beta-Lactamases; Ceftazidime; Cephalosporins; Humans; Imipenem; Membrane Proteins; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1992 |
Comparative in-vitro activities of newer cephalosporins cefclidin, cefepime, and cefpirome against ceftazidime- or imipenem-resistant Pseudomonas aeruginosa.
Topics: beta-Lactamases; Cefepime; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Isoelectric Focusing; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1992 |
Purification and characterization of an imipenem hydrolysing metallo-beta-lactamase from Bacteroides fragilis.
Topics: Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Biotransformation; Cefoxitin; Cephalosporins; Edetic Acid; Humans; Hydrolysis; Imipenem; Isoelectric Point; Kinetics; Microbial Sensitivity Tests; Molecular Weight; Penicillins | 1992 |
In vitro activity of E1040 against imipenem-resistant Pseudomonas aeruginosa strains.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1992 |
In vitro and in vivo antibacterial activities of meropenem, a new carbapenem antibiotic.
Topics: Animals; Bacterial Infections; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Male; Meropenem; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Thienamycins | 1992 |
An in-vitro and in-vivo comparison of the activity of beta-lactamase inhibitor combinations with imipenem and cephalosporins against Escherichia coli producing TEM-1 or TEM-2 beta-lactamase.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cell Cycle; Cephalosporins; Colony Count, Microbial; Diffusion; Drug Therapy, Combination; Escherichia coli; Female; Imipenem; Mice; Microbial Sensitivity Tests | 1991 |
In-vitro activity and beta-lactamase stability of SR 44337, a new long acting cephalosporin.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Ceftriaxone; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Enterobacteriaceae; Enzyme Stability; Imipenem | 1991 |
The in vitro activity of flomoxef compared to four other cephalosporins and imipenem.
Topics: Cephalosporins; Imipenem; Microbial Sensitivity Tests | 1991 |
Post-antibiotic effect of beta-lactam antibiotics on gram-negative bacteria in relation to morphology, initial killing and MIC.
Topics: Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Enterobacteriaceae; Humans; Imipenem; Luminescent Measurements; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1991 |
In vitro evaluation of GR69153, a novel catechol-substituted cephalosporin.
Topics: Bacteria; Bacterial Outer Membrane Proteins; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Culture Media; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Plasmids | 1991 |
In vitro synergistic activity between meropenem and other beta-lactams against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefazolin; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Imipenem; Meropenem; Methicillin Resistance; Staphylococcus aureus; Thienamycins | 1991 |
Factors that influence the permeability assay of the outer membrane of Pseudomonas aeruginosa.
Topics: beta-Lactamases; Cell Membrane Permeability; Cephalosporins; Diffusion; Enzyme Induction; Imipenem; Pseudomonas aeruginosa; Temperature | 1991 |
[Recommendations for the indication-justified use of antibiotics. 1. beta-lactam antibiotics].
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamase Inhibitors; Cephalosporins; Cilastatin; Drug Combinations; Drug Resistance, Microbial; Humans; Imipenem; Penicillin Resistance | 1991 |
[Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. II. In vitro combined effects of sulbactam/cefoperazone with imipenem/cilastatin, cefuzonam, flomoxef, amikacin or tobramycin].
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Cefoperazone; Ceftizoxime; Cephalosporins; Cilastatin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Sulbactam; Tobramycin | 1991 |
The effect of amphotericin B, aztreonam, imipenem and cephalosporins on the bone marrow progenitor cell activity.
Topics: Amphotericin B; Animals; Aztreonam; Bone Marrow Cells; Cephalosporins; Colony-Forming Units Assay; Evaluation Studies as Topic; Female; Humans; Imipenem; Mice; Mice, Inbred C57BL; Stem Cells | 1991 |
[Susceptibilities of clinical bacterial isolates to antimicrobial agents. A study mainly focused on imipenem. Research Group for Testing Imipenem Susceptibility on Clinical Isolates].
Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Microbial Sensitivity Tests | 1990 |
Comparative in vitro activity of the new quinolone sparfloxacin (CI-978, AT-4140) against nosocomial gram-negative bloodstream isolates.
Topics: Amikacin; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Cross Infection; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Pseudomonas aeruginosa; Sepsis; Tobramycin | 1990 |
Influence of subinhibitory concentrations of cephalosporins on the serum sensitivity of Pseudomonas aeruginosa.
Topics: Amikacin; Blood Bactericidal Activity; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Complement C9; Complement System Proteins; Dose-Response Relationship, Drug; Humans; Imipenem; Lipopolysaccharides; Pseudomonas aeruginosa; Serum Bactericidal Test | 1990 |
Monotherapy for empirical management of febrile neutropenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Costs and Cost Analysis; Fever; Humans; Imipenem; Infections; Neutropenia; Quinolones | 1990 |
In vitro antibacterial activity and beta-lactamase stability of the new carbapenem LJC10,627.
Topics: Bacteria; beta-Lactamases; Carbapenems; Cefpirome; Ceftazidime; Cephalosporins; Humans; Imipenem; Molecular Structure; Thienamycins | 1990 |
[Combined antimicrobial preparations].
Topics: Bacteria; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Humans; Imipenem; Penicillins | 1990 |
[In vitro synergism of two-drug combinations among cefamandole, flomoxef and imipenem against MRSA].
Topics: Cefmetazole; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Imipenem; Methicillin; Penicillin Resistance; Staphylococcus aureus | 1990 |
[Influence of Mueller-Hinton broth on the in vitro activities of cefuzoname, flomoxef, imipenem, and minocycline against Staphylococcus aureus].
Topics: Ceftizoxime; Cephalosporins; Culture Media; Drug Resistance, Microbial; Imipenem; Minocycline; Staphylococcus aureus; Tetracyclines | 1990 |
Comparative chemotherapeutic activity of cefpirome and imipenem in experimental infections.
Topics: Abscess; Animals; Bacterial Infections; Cefotaxime; Cefpirome; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Granuloma; Imipenem; Male; Mice; Mice, Hairless; Mice, Inbred C3H; Pneumonia; Rats; Rats, Inbred Strains; Sepsis; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections | 1990 |
Comparative in vitro antibacterial activity of the new carbapenem meropenem (SM-7338).
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins; Ticarcillin | 1989 |
The kinetics of CAZ-5, a novel SHV-related plasmid-mediated beta-lactamase with enhanced hydrolytic activity against ceftazidime.
Topics: beta-Lactamases; Ceftazidime; Cephalosporins; Cephamycins; Hydrolysis; Imipenem; Isoenzymes; Kinetics; Klebsiella pneumoniae; Plasmids | 1989 |
Cholangitis after the Kasai operation for biliary atresia.
Topics: Anti-Bacterial Agents; Biliary Atresia; Cephalosporins; Cholangitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Infant; Methylprednisolone; Portoenterostomy, Hepatic; Postoperative Care; Postoperative Complications; Prognosis | 1989 |
In-vitro activity of FCE 22101 against respiratory tract pathogens with reference to production of beta-lactamases.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Carbapenems; Ceftibuten; Cephalosporins; Imipenem; Microbial Sensitivity Tests; Respiratory Tract Infections | 1989 |
In vitro evaluation of antibiotics for treatment of meningitis caused by Campylobacter fetus subspecies fetus.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Campylobacter fetus; Campylobacter Infections; Cephalosporins; Child, Preschool; Chloramphenicol; Gentamicins; Humans; Imipenem; Infant, Newborn; Meningitis; Microbial Sensitivity Tests; Middle Aged | 1989 |
Clostridium perfringens type A. Comparison of in vitro and in vivo activity of twelve antimicrobial drugs.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Clostridium perfringens; Fosfomycin; Gas Gangrene; Imipenem; Metronidazole; Mice; Microbial Sensitivity Tests; Oxacillin; Penicillin G; Thienamycins; Vancomycin | 1986 |
Antimicrobial susceptibility of group B streptococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Female; Humans; Imipenem; Microbial Sensitivity Tests; Nalidixic Acid; Penicillins; Quinolines; Streptococcus agalactiae; Thienamycins; Trimethoprim | 1986 |
The in-vitro activity of a novel penem FCE 22101 compared to other beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Gram-Negative Bacteria; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Thienamycins | 1985 |
[Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cephalosporins; Citrobacter; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Enterobacter; Enterobacteriaceae; Escherichia coli; Humans; Imipenem; Klebsiella; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; Thienamycins | 1988 |
Serum bactericidal test in volunteers--a review.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Evaluation; Drug Therapy, Combination; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Male; Penicillins; Pseudomonas aeruginosa; Staphylococcus aureus; Thienamycins | 1986 |
In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Time Factors; Tobramycin | 1986 |
In vitro activity of CGP 31608, a new penem.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Bacteroides; Carrier Proteins; Cephalosporins; Clostridium; Enterobacteriaceae; Haemophilus influenzae; Hexosyltransferases; Imipenem; Lactams; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Neisseria; Penicillin-Binding Proteins; Peptidyl Transferases; Pseudomonas aeruginosa; Staphylococcus; Streptococcus; Thienamycins | 1987 |
In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa.
Topics: Aminoglycosides; beta-Lactamases; Cefepime; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance; Drug Stability; Gentamicins; Hydrolysis; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1988 |
[Third generation cephalosporins, monobactams and carbapenems].
Topics: Aztreonam; Bacteria; Bacterial Infections; Cefotaxime; Cephalosporins; Imipenem; Thienamycins | 1988 |
Salt-supplemented medium for testing methicillin-resistant staphylococci with newer beta-lactams.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Clavulanic Acids; Culture Media; Drug Therapy, Combination; Humans; Imipenem; Methicillin; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Sodium Chloride; Staphylococcus; Staphylococcus aureus; Ticarcillin | 1988 |
Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Penicillins; Ticarcillin | 1988 |
Beta-lactam resistance in Aeromonas spp. caused by inducible beta-lactamases active against penicillins, cephalosporins, and carbapenems.
Topics: Aeromonas; Aged; Anti-Bacterial Agents; Aztreonam; Bacterial Outer Membrane Proteins; beta-Lactamases; Cephalosporins; Drug Resistance, Microbial; Enzyme Induction; Humans; Imipenem; Isoelectric Focusing; Male; Penicillins | 1988 |
A survey of the kinetic parameters of class C beta-lactamases. Cephalosporins and other beta-lactam compounds.
Topics: Aztreonam; beta-Lactamases; Cephalosporins; Hydrolysis; Imipenem; Kinetics; Moxalactam; Substrate Specificity | 1988 |
In vitro antibacterial activity and beta-lactamase stability of CL 118523, an aminothiazolyl iminomethoxy cephalosporin.
Topics: Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Stability; Enterobacteriaceae; Enzyme Induction; Imipenem; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Thienamycins | 1987 |
In-vitro activity of cefpirome (HR-810), WIN-49375, BMY-28142 and other antibiotics against nosocomially important isolates from cancer patients.
Topics: Anti-Bacterial Agents; Cefepime; Cefpirome; Cephalosporins; Ciprofloxacin; Cross Infection; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Neoplasms; Quinolines; Thienamycins | 1986 |
Antibiotics in the second half of the 1980s. Areas of future development and the effect of new agents on aminoglycoside use.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Humans; Imipenem; Monobactams; Penicillin Resistance; Penicillins; Structure-Activity Relationship; Thienamycins | 1986 |
Activity of newer antimicrobial agents against Aeromonas hydrophila.
Topics: Aeromonas; Anti-Bacterial Agents; Cephalosporins; Humans; Imipenem; Lactams; Monobactams; Penicillins; Quinolines; Thienamycins | 1986 |
Nosocomial and nursing home-acquired pneumonia. Recent therapeutic advances.
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Cilastatin; Clavulanic Acid; Clavulanic Acids; Cross Infection; Cyclopropanes; Humans; Imipenem; Nursing Homes; Pneumonia; Thienamycins; Ticarcillin | 1987 |
Comparative in vitro activities of ampicillin, BMY 28142, and imipenem against Mycobacterium avium complex.
Topics: Ampicillin; Cefepime; Cephalosporins; Humans; Imipenem; Microbial Sensitivity Tests; Mycobacterium avium; Thienamycins | 1987 |
The in-vivo postantibiotic effect of imipenem and other new antimicrobials.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Female; Half-Life; Imipenem; Kinetics; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Thienamycins | 1986 |
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clindamycin; Fusidic Acid; Imipenem; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Thienamycins; Tobramycin; Vancomycin | 1987 |
Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem.
Topics: Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Cefoxitin; Cephalosporins; Drug Resistance, Microbial; Imipenem; Isoelectric Point; Kinetics; Microbial Sensitivity Tests; Moxalactam; Nephelometry and Turbidimetry; Thienamycins | 1986 |
Comparative in vitro activity and beta-lactamase stability of CGP 31523A, a new aminothiazolyl cephalosporin.
Topics: Aztreonam; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Carbenicillin; Cefotaxime; Ceftazidime; Cephalosporins; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Penicillin Resistance; Thienamycins | 1986 |
In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin.
Topics: Bacteria; Cefepime; Cephalosporins; Drug Resistance, Microbial; Imipenem; Microbial Sensitivity Tests; Mutation; Thienamycins | 1985 |
In vitro antibacterial activity of imipenem against Pseudomonas and Staphylococcus species. Comparison with thirteen other antimicrobial agents.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Imipenem; Microbial Sensitivity Tests; Pseudomonas; Staphylococcus aureus; Thienamycins | 1985 |
Evidence for nonspecific induction of beta-lactamase in overproducing variants of Enterobacter cloacae and Citrobacter freundii.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefamandole; Cefoxitin; Cephalosporins; Citrobacter; Culture Media; Enterobacter; Enterobacteriaceae; Enzyme Induction; Imipenem; Penicillin Resistance; Penicillins; Thienamycins | 1985 |
Comparative in-vitro activity of Sch 34343, imipenem, cefpirome and cefotaxime.
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Cefpirome; Cephalosporins; Escherichia coli; Haemophilus influenzae; Imipenem; Lactams; Microbial Sensitivity Tests; Pseudomonas; Staphylococcus; Streptococcus; Thienamycins | 1985 |
The in vitro activity of the newer beta-lactam antibiotics against 124 strains of gram-negative bacilli.
Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Cephalosporins; Enterobacteriaceae; Gentamicins; Imipenem; Microbial Sensitivity Tests; Moxalactam; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Ticarcillin | 1985 |
Susceptibility of Bordetella pertussis to cephalosporin derivatives and imipenem.
Topics: Anti-Bacterial Agents; Bordetella pertussis; Cephalosporins; Imipenem; Microbial Sensitivity Tests; Thienamycins | 1984 |
Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods.
Topics: Aerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam | 1982 |
In vitro comparative activity of moxalactam, GR 20263, and N-formimidoyl thienamycin to other beta-lactam antibiotics and tobramycin against enterobacteriaceae and staphylococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Cephalosporins; Cephamycins; Enterobacteriaceae; Imipenem; Microbial Sensitivity Tests; Moxalactam; Staphylococcus; Tobramycin | 1982 |
In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamases; beta-Lactams; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Hydrolysis; Imipenem; Microbial Sensitivity Tests; Moxalactam; Thienamycins | 1981 |
In vitro activity of seventeen antimicrobial agents against Gardnerella vaginalis.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Cefoperazone; Cephalosporins; Clindamycin; Drug Resistance, Microbial; Erythromycin; Gardnerella vaginalis; Haemophilus; Imipenem; Microbial Sensitivity Tests; Nitroimidazoles; Quinolines; Quinolones; Thienamycins | 1982 |
Effectiveness of the antimicrobial removal device, BACTEC 16B medium, and thiol broth in neutralizing antibacterial activities of imipenem, norfloxacin, and related agents.
Topics: Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Blood; Cefoxitin; Ceftazidime; Cephalosporins; Culture Media; Evaluation Studies as Topic; Humans; Imipenem; Moxalactam; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Sulfhydryl Compounds; Thienamycins; Urine | 1984 |
Bactericidal activity of antibiotics against Campylobacter fetus subspecies intestinalis.
Topics: Ampicillin; Campylobacter; Campylobacter fetus; Cefoperazone; Cefotaxime; Cephalosporins; Cephalothin; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Streptomycin | 1981 |
Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1980 |
In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Ceftazidime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam | 1981 |
N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Microbial Sensitivity Tests; Moxalactam | 1981 |
In vitro comparison of N-formimidoyl thienamycin, piperacillin, cefotaxime, and cefoperazone.
Topics: Aerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Humans; Imipenem; Lactams; Penicillins; Piperacillin; Species Specificity | 1981 |
Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
Topics: Azlocillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Imipenem; Lactams; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin; Serratia marcescens | 1981 |
Interaction between non-classical beta-lactam compounds and the Zn2+-containing G and serine R61 and R39 D-alanyl-D-alanine peptidases.
Topics: Actinomycetaceae; Amdinocillin; beta-Lactams; Carboxypeptidases; Cefoxitin; Cephalosporins; Clavulanic Acid; Drug Interactions; Endopeptidases; Enzyme Inhibitors; Imipenem; Kinetics; Penicillanic Acid; Penicillins; Quinoxalines; Serine-Type D-Ala-D-Ala Carboxypeptidase; Streptomyces; Zinc | 1981 |
Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
Topics: Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin | 1982 |
In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; beta-Lactams; Cefotaxime; Cefoxitin; Cefsulodin; Cephalosporins; Cephamycins; Imipenem; Lincomycin; Metronidazole; Moxalactam | 1981 |
Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Imipenem; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections | 1981 |
Susceptibility of gram-positive cocci to various antibiotics, including cefotaxime, moxalactam, and N-formimidoyl thienamycin.
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Staphylococcus; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 1981 |
The comparative activities of N-formimidoyl theinamycin (MK0787), moxalactam, cefotaxime and cefoperazone against Yersinia enterocolitica and Listeria monocytogenes.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Listeria monocytogenes; Moxalactam; Yersinia | 1982 |
In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
Topics: Acinetobacter; Bacteria; Cefotaxime; Cephalosporins; Cephamycins; Cross Infection; Drug Resistance, Microbial; Enterobacter; Escherichia coli; Gentamicins; Imipenem; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia; Thienamycins | 1982 |
Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; Bacteroides fragilis; Cefmenoxime; Cefotaxime; Cefotetan; Cephalosporins; Cephamycins; Imipenem; Microbial Sensitivity Tests; Thienamycins | 1983 |
In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Synergism; Imipenem; Kanamycin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Thienamycins | 1983 |
Pharmacokinetics and therapeutic efficacy of imipenem, ceftazidime, and ceftriaxone in experimental meningitis due to an ampicillin- and chloramphenicol-resistant strain of Haemophilus influenzae type b.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Chloramphenicol; Haemophilus influenzae; Humans; Imipenem; Infant; Kinetics; Male; Meningitis, Haemophilus; Penicillin Resistance; Rabbits; Thienamycins | 1984 |
In vitro activity of N-formimidoyl thienamycin (MK 0787) compared with other beta-lactamase stable cephalosporins against beta-lactamase producing Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Staphylococcus aureus; Thienamycins | 1984 |
[Induction of beta-lactamases in Enterobacter cloacae with beta-lactam antibiotics].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Drug Combinations; Electrophoresis, Polyacrylamide Gel; Enterobacter; Enterobacteriaceae; Enzyme Induction; Imipenem; Lactams; Penicillin Resistance; Penicillins; Thienamycins | 1984 |
In-vitro antagonism by N-formimidoyl thienamycin and cefoxitin of second and third generation cephalosporins in Aeromonas hydrophila and Serratia marcescens.
Topics: Aeromonas; Anti-Bacterial Agents; beta-Lactamases; Cefoxitin; Cephalosporins; Drug Resistance, Microbial; Enzyme Induction; Imipenem; Serratia marcescens; Thienamycins | 1983 |
Antagonism by chloramphenicol of broad-spectrum beta-lactam antibiotics against Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Chloramphenicol; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Thienamycins; Time Factors | 1984 |
Comparison of ceftazidime and N-formimidoyl thienamycin against gentamicin-susceptible and resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Gentamicins; Imipenem; Pseudomonas aeruginosa; Thienamycins | 1983 |
Cefoperazone against carbenicillin-resistant isolates of Pseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoyl thienamycin.
Topics: beta-Lactamases; Carbenicillin; Cefoperazone; Cephalosporins; Conjugation, Genetic; Imipenem; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas aeruginosa; Thienamycins | 1983 |
The morphological response of Pseudomonas aeruginosa to azthreonam, cefoperazone, ceftazidime and N-formimidoyl thienamycin.
Topics: Anti-Bacterial Agents; Aztreonam; Cefoperazone; Ceftazidime; Cephalosporins; Imipenem; Microbial Sensitivity Tests; Microscopy, Electron; Nephelometry and Turbidimetry; Pseudomonas aeruginosa; Spheroplasts; Thienamycins | 1984 |
[Comparative in vitro activity of 5 beta-lactams (cefoperazone, cefsulodin, ceftazidime, azthreonam, N-formimidoyl-thienamycin) on 90 strains of Pseudomonas aeruginosa with various levels of resistance to ticarcillin].
Topics: Anti-Bacterial Agents; Aztreonam; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Imipenem; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Thienamycins; Ticarcillin | 1984 |
In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter fetus; Campylobacter Infections; Cefoperazone; Cephalosporins; Chickens; Humans; Imipenem; Lactams; Leucomycins; Microbial Sensitivity Tests | 1981 |
In vitro activity of HR 810, a new cephalosporin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefpirome; Cephalosporins; Imipenem; Microbial Sensitivity Tests; Thienamycins | 1984 |
Trends in the development of beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Humans; Imipenem; Penicillins; Technology, Pharmaceutical; Thienamycins | 1984 |
Comparative stability of first, second and third generation cephalosporins and N-formimidoyl thienamycin against gram-negative beta-lactamases.
Topics: beta-Lactamases; Cephalosporins; Drug Stability; Gram-Negative Bacteria; Imipenem; Thienamycins | 1983 |
Stability of N-formimidoylthienamycin in aqueous solution.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Stability; Hydrogen-Ion Concentration; Imipenem; Kinetics; Lactams; Penicillins; Phosphates; Solutions | 1981 |
Activity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia.
Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Cross Infection; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Sepsis | 1982 |
In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins.
Topics: Anti-Bacterial Agents; Cephalosporins; Cephamycins; Culture Media; Imipenem; Microbial Sensitivity Tests; Mycobacterium; Thienamycins | 1982 |
In vitro activity and beta-lactamase stability of N-formimidoyl thienamycin compared to that of second and third generation cephalosporins.
Topics: beta-Lactamase Inhibitors; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Imipenem; Pseudomonas; Thienamycins | 1982 |
In vitro susceptibility of Nocardia asteroides to N-formimidoyl thienamycin and several cephalosporins.
Topics: Anti-Bacterial Agents; Cephalosporins; Imipenem; Lactams; Microbial Sensitivity Tests; Nocardia asteroides | 1981 |
Failure of cefotaxime treatment in two children with meningitis caused by highly penicillin-resistant Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Humans; Imipenem; Infant; Male; Meningitis, Pneumococcal; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Thienamycins | 1995 |
[In vitro activity of six beta-lactams against 295 strains of enterobacteriaceae and P. aeruginosa isolated from neutropenic patients].
Topics: Cefepime; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Humans; Imipenem; In Vitro Techniques; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins | 1995 |
Postantibiotic effect of carbapenems against Pseudomonas aeruginosa.
Topics: Animals; Ceftazidime; Cephalosporins; Female; Imipenem; Meropenem; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1995 |
Appearance of resistance to beta-lactam antibiotics during therapy for Streptococcus pneumoniae meningitis.
Topics: beta-Lactam Resistance; Cefuroxime; Cephalosporins; Child; Humans; Imipenem; Male; Meningitis, Pneumococcal; Penicillins; Streptococcus pneumoniae; Vancomycin | 1995 |
Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.
Topics: Aztreonam; Cefepime; Cefotaxime; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Sensitivity and Specificity | 1995 |
[A clinical study on chemotherapies for chorioamnionitis].
Topics: Amoxicillin; Ceftazidime; Cephalosporins; Chorioamnionitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fetal Membranes, Premature Rupture; Humans; Imipenem; Obstetric Labor, Premature; Pregnancy | 1994 |
Efficacy of a novel injectable cephalosporin, Cefclidin, on the experimental complicated urinary tract infections with urinary stones caused by Pseudomonas aeruginosa and Proteus mirabilis.
Topics: Animals; Cephalosporins; Disease Models, Animal; Drug Resistance, Microbial; Female; Imipenem; Kidney Calculi; Proteus Infections; Proteus mirabilis; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Urinary Bladder Calculi; Urinary Calculi; Urinary Tract Infections | 1994 |
Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.
Topics: beta-Lactamases; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Ciprofloxacin; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; International Cooperation; Microbial Sensitivity Tests | 1994 |
Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenes.
Topics: Aged; Bacterial Outer Membrane Proteins; beta-Lactamases; Cell Membrane Permeability; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans; Imipenem; Mutation | 1994 |
[Antibiotic efficacies of combined uses of arbekacin and various antibiotics against methicillin-resistant Staphylococcus aureus].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Drug Therapy, Combination; Fosfomycin; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Staphylococcus aureus | 1994 |
[Basic studies on combination effects of arbekacin and beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Cephalosporins; Cilastatin; Dibekacin; Drug Therapy, Combination; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus | 1994 |
[Transfer of resistance to new cephalosporins and carbapenems (Imipenem)].
Topics: Cephalosporins; Drug Resistance, Microbial; Imipenem; R Factors | 1994 |
Substrate-induced inactivation of the OXA2 beta-lactamase.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Enzyme Activation; Hydrolysis; Imipenem; Kinetics; Penicillins | 1993 |
Activity of imipenem, third-generation cephalosporins, aztreonam and ciprofloxacin against multi-resistant gram-negative bacilli isolated from Chilean hospitals.
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Chile; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Drug Synergism; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Indicators and Reagents; Microbial Sensitivity Tests | 1993 |
Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Europe; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospital Units; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Piperacillin; Prevalence | 1993 |
Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.
Topics: Amikacin; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Fusidic Acid; Gentamicins; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Staphylococcus aureus | 1993 |
[In vitro effects of combinations of antibiotics against highly-fosfomycin-resistant, methicillin-resistant Staphylococcus aureus. With special reference to efficacies of combinations of imipenem/cilastatin and cephems].
Topics: Cephalosporins; Cilastatin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Imipenem; Methicillin Resistance; Staphylococcus aureus | 1993 |
[A nationwide survey of antimicrobial susceptibilities of clinical isolates to antibiotics in Japan (1988-1990)].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cephalosporins; Humans; Imipenem; Japan; Microbial Sensitivity Tests; Penicillins; Time Factors | 1993 |
Cephalosporins having a heterocyclic catechol in the C3 side chain. I. Enhancement of efficacy against gram-negative bacteria.
Topics: Animals; Ceftazidime; Cephalosporins; Half-Life; Imipenem; Mice; Microbial Sensitivity Tests; Pseudomonas Infections; Stereoisomerism; Structure-Activity Relationship | 1993 |
In vitro activity of tosufloxacin against Pseudomonas pseudomallei, Salmonella spp. and other Enterobacteriaceae.
Topics: Anti-Infective Agents; Burkholderia pseudomallei; Ceftazidime; Cephalosporins; Enterobacteriaceae; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Naphthyridines; Salmonella; Thienamycins | 1995 |
Autolysis of methicillin-resistant Staphylococcus aureus is involved in synergism between imipenem and cefotiam.
Topics: Bacterial Proteins; Bacteriolysis; Base Sequence; Carrier Proteins; Cefotiam; Cephalosporins; Drug Synergism; Hexosyltransferases; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Polymerase Chain Reaction; Staphylococcus aureus; Thienamycins | 1995 |
Impact of different classes antimicrobial agents on plasma endotoxin activity.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Blood Pressure; Cefotaxime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Gentamicins; Imipenem; Male; Peritoneal Diseases; Peritoneum; Rats; Rats, Wistar; Thienamycins | 1996 |
In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Chromogenic Compounds; Drug Resistance, Microbial; Gram-Negative Bacteria; Imipenem; Microbial Sensitivity Tests; Slovakia; Thienamycins | 1995 |
Relationship between outer membrane protein profiles and resistance to ceftazidime, imipenem, and ciprofloxacin in Pseudomonas aeruginosa isolates from bacteremic patients.
Topics: Anti-Infective Agents; Bacteremia; Bacterial Outer Membrane Proteins; Ceftazidime; Cephalosporins; Ciprofloxacin; Humans; Imipenem; Pseudomonas aeruginosa; Thienamycins | 1996 |
[Nephrotoxicity and drug interaction of vancomycin (2)].
Topics: Animals; Blood Urea Nitrogen; Cefoperazone; Ceftazidime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Creatinine; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Imipenem; Kidney; Male; Organ Size; Rabbits; Vancomycin | 1996 |
[In vitro and in vivo activities of sulopenem compared with those of imipenem and cephalosporins].
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; Cefotaxime; Ceftizoxime; Cephalosporins; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Guinea Pigs; Imipenem; Klebsiella Infections; Lactams; Lung Diseases; Mice; Mice, Inbred ICR; Thienamycins | 1996 |
[In vitro and in vivo antibacterial activities of sulopenem, a new penem antibiotic].
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Lactams; Male; Meropenem; Mice; Thienamycins | 1996 |
[In vitro activities of sulopenem, a new parenteral penem, against anaerobes].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactamases; beta-Lactams; Cecum; Cefoperazone; Ceftizoxime; Cephalosporins; Clostridioides difficile; Drug Stability; Drug Therapy, Combination; Imipenem; Lactams; Male; Mice; Mice, Inbred ICR; Sulbactam; Thienamycins | 1996 |
[Antimicrobial activities of meropenem against clinically isolated strains. The result against strains isolated from blood and cerebrospinal fluid].
Topics: Ampicillin; Blood; Cefotaxime; Cephalosporins; Cerebrospinal Fluid; Escherichia coli; Humans; Imipenem; Listeria monocytogenes; Meningitis, Bacterial; Meropenem; Penicillins; Sepsis; Streptococcus agalactiae; Streptococcus pneumoniae; Thienamycins | 1996 |
Direct application of Etest to gram-positive cocci from blood cultures: quick and reliable minimum inhibitory concentration data.
Topics: Anti-Bacterial Agents; Blood; Cefotaxime; Cephalosporins; Culture Media; Erythromycin; Gentamicins; Gram-Positive Cocci; Imipenem; Microbial Sensitivity Tests; Penicillin G; Penicillins; Thienamycins; Vancomycin | 1996 |
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cell Division; Cephalosporins; Drug Resistance, Microbial; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Quinolones; Streptococcus pneumoniae; Thienamycins; Time Factors; Vancomycin | 1996 |
[Antibacterial activities of combination uses of cefpirome with various antibiotics in vitro against clinically isolated glucose non-fermentative gram-negative rods: part 1. the results against Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefpirome; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Imipenem; Piperacillin; Pseudomonas aeruginosa; Tobramycin | 1996 |
Differential release of smooth-type lipopolysaccharide from Pseudomonas aeruginosa treated with carbapenem antibiotics and its relation to production of tumor necrosis factor alpha and nitric oxide.
Topics: Carbapenems; Ceftazidime; Cephalosporins; Endotoxins; Imipenem; Lipopolysaccharides; Lymphotoxin-alpha; Meropenem; Nitric Oxide; Pseudomonas aeruginosa; Thienamycins; Tumor Necrosis Factor-alpha | 1996 |
Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Enterobacter; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Hospital Bed Capacity; Hospitals, Teaching; Humans; Imipenem; Intensive Care Units; Klebsiella pneumoniae; Lung; Microbial Sensitivity Tests; Product Surveillance, Postmarketing; Pseudomonas aeruginosa; Risk Factors; Thienamycins; Wounds and Injuries | 1996 |
Bacteremia versus endotoxemia in experimental mouse leukopenia--role of antibiotic chemotherapy.
Topics: Animals; Antibodies, Monoclonal; Bacteremia; Ceftazidime; Cephalosporins; Cyclophosphamide; Endotoxemia; Escherichia coli; Escherichia coli Infections; Female; Galactosamine; Imipenem; Immunity, Innate; Interferon-gamma; Leukopenia; Mice; O Antigens; Thienamycins | 1996 |
In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii.
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Thienamycins; Tobramycin | 1996 |
Antibacterial activity of T-5575, a novel 2-carboxypenam, and its stability to beta-lactamase.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Hydrolysis; Imipenem; Kinetics; Mutation | 1997 |
Therapeutic effects of cefozopran against experimental mixed urinary tract infection with Enterococcus faecalis and Pseudomonas aeruginosa in mice.
Topics: Ampicillin; Animals; Cefozopran; Ceftazidime; Cephalosporins; Cilastatin; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Imipenem; Mice; Mice, Inbred CBA; Ofloxacin; Pseudomonas Infections; Urinary Tract Infections | 1997 |
In vitro and in vivo evaluation of BO-2727 against imipenem- and/or meropenem-resistant Pseudomonas aeruginosa.
Topics: Animals; Carbapenems; Ceftazidime; Cephalosporins; Culture Media; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Imipenem; In Vitro Techniques; Male; Meropenem; Mice; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1997 |
In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins | 1997 |
Hydrolysis of imipenem, meropenem, ceftazidime, and cefepime by multiresistant nosocomial strains of Sphingobacterium multivorum.
Topics: Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Flavobacterium; Gram-Negative Bacterial Infections; Humans; Hydrolysis; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins | 1997 |
Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Ciprofloxacin; Clinical Trials as Topic; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Isoelectric Focusing; Meropenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Tobramycin | 1997 |
Experimental pseudomonal posttraumatic endophthalmitis in a swine model. Treatment with ceftazidime, amikacin, and imipenem.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Follow-Up Studies; Imipenem; Injections; Pseudomonas aeruginosa; Pseudomonas Infections; Sclera; Swine; Thienamycins; Vitreous Body | 1997 |
In-vitro study of the synergy between beta-lactam antibiotics and glycopeptides against enterococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Dose-Response Relationship, Drug; Drug Synergism; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Glycopeptides; Imipenem; Microbial Sensitivity Tests; Piperacillin; Teicoplanin; Vancomycin | 1997 |
Influence of changes in pancreatic tissue morphology and capillary blood flow on antibiotic tissue concentrations in the pancreas during the progression of acute pancreatitis.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Capillaries; Cefotaxime; Cephalosporins; Disease Progression; Imipenem; Male; Necrosis; Pancreas; Pancreatitis, Acute Necrotizing; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Thienamycins | 1997 |
[The effect of cefepime on ceftazidime, cefotaxime and imipenem resistant strains of Acinetobacter, Xanthomonas, Pseudomonas, Flavobacterium, Sphingobacterium and on producers of extended spectrum beta-lactamases (ESBL) with resistance transfer].
Topics: Acinetobacter; Bacteria; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Resistance, Multiple; Flavobacterium; Imipenem; Pseudomonas; R Factors; Thienamycins; Xanthomonas | 1997 |
Evolution of extended spectrum cephalosporin resistance in the pneumococcus.
Topics: Cefotaxime; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Imipenem; Penicillin Resistance; Streptococcus pneumoniae; Thienamycins | 1997 |
Oxacillin-hydrolyzing beta-lactamase involved in resistance to imipenem in Acinetobacter baumannii.
Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Enzyme Inhibitors; Hydrolysis; Imipenem; Isoelectric Point; Kinetics; Lactams; Molecular Weight; Oxacillin; Penicillins; Sodium Chloride; Substrate Specificity; Thienamycins | 1997 |
Clostridium difficile infection in obstetric and gynecologic patients.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; Cefoxitin; Cephalexin; Cephalosporins; Cephamycins; Ciprofloxacin; Clindamycin; Clostridioides difficile; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fever; Gentamicins; Humans; Imipenem; Incidence; Middle Aged; Nausea; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination; Vomiting | 1997 |
[Survey of sensitivities of clinical isolates to antibacterial agents (annual report)].
Topics: 4-Quinolones; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Cocci; Haemophilus influenzae; Humans; Imipenem; Meropenem; Monobactams; Penicillins; Pseudomonas aeruginosa; Serratia marcescens; Thienamycins | 1997 |
Therapeutic efficacy of intravitreal ceftazidime, imipenem, and amikacin in a swine model of posttraumatic Pseudomonas aeruginosa endophthalmitis.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Imipenem; Pseudomonas Infections; Swine; Vitreous Body | 1997 |
Comparative in vitro interactions of ceftazidime, meropenem, and imipenem with amikacin on multiresistant Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Interactions; Drug Resistance, Multiple; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins | 1997 |
In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.
Topics: Administration, Oral; Animals; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier Proteins; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Drug Stability; Hexosyltransferases; Imipenem; Mice; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pneumonia, Staphylococcal; Prodrugs; Thienamycins | 1997 |
Predictive value of several signs of infection as surrogate markers for mortality in a neutropenic guinea pig model of Pseudomonas aeruginosa sepsis.
Topics: Animals; Anti-Bacterial Agents; Biomarkers; Ceftazidime; Cephalosporins; Diarrhea; Disease Models, Animal; Female; Guinea Pigs; Imipenem; Meropenem; Movement Disorders; Neutropenia; Predictive Value of Tests; Pseudomonas Infections; Regression Analysis; Respiration; Thienamycins; Time Factors; Tobramycin; Weight Loss | 1997 |
Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporinase; Cephalosporins; Cohort Studies; Colombia; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Reproducibility of Results; Staphylococcus; Sulbactam | 1997 |
Quinolone-resistant Salmonella paratyphi B meningitis in a newborn: a case report.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Brain Abscess; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Histocytochemistry; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Meningitis, Bacterial; Microbial Sensitivity Tests; Paratyphoid Fever; Salmonella paratyphi B; Thienamycins; Tomography, X-Ray Computed | 1997 |
Cerebral nocardia abscesses in a patient with AIDS: correlation of magnetic resonance and white cell scanning images with neuropathological findings.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Anti-Bacterial Agents; Brain Abscess; Ceftriaxone; Cephalosporins; Drug Therapy, Combination; Humans; Imipenem; Magnetic Resonance Imaging; Male; Nocardia asteroides; Nocardia Infections; Radionuclide Imaging; Thienamycins | 1997 |
Activity of cefepime against resistant strains of Pseudomonas aeruginosa.
Topics: beta-Lactam Resistance; Cefepime; Cephalosporins; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins | 1997 |
Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Blood; Carbapenems; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Respiratory Tract Infections; Saudi Arabia; Urinary Tract Infections; Wounds and Injuries | 1997 |
[Pneumococcal infections: penicillin resistance and therapeutic implications].
Topics: Amoxicillin; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactam Resistance; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Microbial; Erythromycin; Humans; Imipenem; Patient Care Planning; Penicillin G; Penicillin Resistance; Penicillins; Pleural Effusion; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Tetracycline Resistance; Thienamycins; Tracheal Diseases | 1995 |
[Comparative activity of meropenem and other antibiotics against the pathogens of nosocomial infections].
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Therapy, Combination; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins; Tobramycin | 1998 |
[The antimicrobial susceptibilities and serotypes of Pseudomonas aeruginosa isolated from sputum].
Topics: Anti-Bacterial Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Monobactams; Penicillins; Piperacillin; Pseudomonas aeruginosa; Serotyping; Sputum; Thienamycins | 1998 |
Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: delay between killing by ceftazidime and imipenem and release of LPS.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Carrier Proteins; Ceftazidime; Cephalosporins; Galactose; Hexosyltransferases; Imipenem; Lipopolysaccharides; Membranes; Microbial Sensitivity Tests; Models, Biological; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Salmonella typhi; Time Factors | 1998 |
Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meni
Topics: Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Cephalosporins; Child; Drug Therapy, Combination; Humans; Imipenem; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae; Thienamycins; Vancomycin | 1998 |
Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotic therapy, and outcome.
Topics: Aged; Bacteremia; Ceftazidime; Cephalosporins; Female; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Pneumonia, Bacterial; Thienamycins; Treatment Outcome | 1998 |
[Drug susceptibility of clinically isolated Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Clarithromycin; Cross Reactions; Drug Resistance, Microbial; Erythromycin; Gastritis; Helicobacter pylori; Humans; Imipenem; Penicillins; Stomach Ulcer; Thienamycins | 1998 |
In vitro activity of polyunsaturated fatty acids on Pseudomonas aeruginosa: relationship to lipid peroxidation.
Topics: Amikacin; Ampicillin Resistance; Anti-Bacterial Agents; Arachidonic Acid; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Fatty Acids, Unsaturated; gamma-Linolenic Acid; Gentamicins; Imipenem; Lipid Peroxidation; Malondialdehyde; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Species Specificity; Thienamycins; Ticarcillin; Tobramycin; Vitamin E | 1998 |
Further studies of transferable antibiotic resistance in strains of Pseudomonas aeruginosa from four clinical settings in three countries.
Topics: Antibiotics, Antitubercular; Cefotaxime; Ceftazidime; Cephalosporins; Conjugation, Genetic; Drug Resistance, Microbial; Drug Resistance, Multiple; Escherichia coli; Humans; Imipenem; Proteus mirabilis; Pseudomonas aeruginosa; Rifampin; Thienamycins | 1998 |
[Evaluation of antibacterial activities of various antibiotics against glucose non-fermentative gram-negative rods other than Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Gram-Negative Aerobic Rods and Cocci; Humans; Imipenem; Minocycline; Penicillin Resistance; Penicillins; Piperacillin; Sulbactam; Thienamycins | 1998 |
Cefepime--assessment of its need at a tertiary care center.
Topics: Adult; Aged; Anti-Infective Agents; Cefepime; Ceftazidime; Cephalosporins; Cilastatin; Ciprofloxacin; Cohort Studies; Drug Utilization Review; Female; Hospitals, University; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Switzerland; Thienamycins | 1998 |
Sensitivity pattern and beta-lactamase production in clinical isolates of Aeromonas strains.
Topics: Aeromonas; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Pakistan; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
Antimicrobial susceptibility testing for Klebsiella pneumoniae isolates resistant to extended-spectrum beta-lactam antibiotics.
Topics: Anti-Infective Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Ciprofloxacin; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Monobactams; Ofloxacin; Thienamycins | 1998 |
Efficacies of cefepime, ceftazidime, and imipenem alone or in combination with amikacin in rats with experimental pneumonia due to ceftazidime-susceptible or -resistant Enterobacter cloacae strains.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Imipenem; Injections, Intraperitoneal; Male; Microbial Sensitivity Tests; Pneumonia; Rats; Rats, Wistar; Thienamycins | 1998 |
[Antimicrobial activity of carbapenem antibiotics against gram-negative bacilli].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Imipenem; Meropenem; Monobactams; Norfloxacin; Tetracycline; Thienamycins | 1998 |
Utility of serial rectal swab cultures for detection of ceftazidime- and imipenem-resistant gram-negative bacilli from patients in the intensive care unit.
Topics: Adult; Aged; beta-Lactam Resistance; Ceftazidime; Cephalosporins; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Rectum; Thienamycins | 1998 |
Prevalence of antimicrobial drug-resistant Streptococcus pneumoniae in Washington State.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Erythromycin; Female; Humans; Imipenem; Infant; Male; Middle Aged; Penicillin Resistance; Pneumococcal Infections; Prevalence; Risk Factors; Serotyping; Streptococcus pneumoniae; Thienamycins; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Washington | 1998 |
[Comparative activity of cefepime, ceftazidime and imipenem in a mouse infection caused by Klebsiella pneumoniae producing a broad spectrum beta-lactamase].
Topics: Animals; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Colony Count, Microbial; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Spleen; Thienamycins | 1998 |
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Erythromycin; Fluoroquinolones; Fusidic Acid; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillins; Skin Diseases, Bacterial; Species Specificity; Streptococcal Infections; Streptococcus; Vancomycin | 1999 |
Canadian Pseudomonas aeruginosa susceptibility study from 48 medical centers: focus on ciprofloxacin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Canada; Carbenicillin; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Geography; Hospitals; Humans; Imipenem; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin; Urinary Tract Infections | 1998 |
Comparative anti-anaerobic activity of Men 10700, a penem antibiotic.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Cephalosporins; Ciprofloxacin; Clindamycin; Clostridium; Fusobacterium; Imipenem; Lactams; Metronidazole; Microbial Sensitivity Tests; Peptostreptococcus; Veillonella | 1998 |
Antibacterial activity of meropenem against Pseudomonas aeruginosa, including antibiotic-induced morphological changes and endotoxin-liberating effects.
Topics: Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Endotoxins; Humans; Imipenem; Lipopolysaccharides; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1998 |
Comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Fever; Humans; Imipenem; Sulbactam; Thienamycins | 1999 |
[Effects of isepamicin and beta-lactam antibiotics on the release of endotoxin from Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Endotoxins; Gentamicins; Imipenem; Penicillins; Piperacillin; Pseudomonas aeruginosa; Thienamycins | 1999 |
[Sensitivity to selected beta-lactam antibiotics of clinical strains of Escherichia coli and Klebsiella pneumoniae].
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Body Fluids; Cephalosporins; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillin Resistance; Reproducibility of Results; Species Specificity | 1998 |
Antibiotic dosing issues in lower respiratory tract infection: population-derived area under inhibitory curve is predictive of efficacy.
Topics: Aged; Anti-Infective Agents; Area Under Curve; Ceftazidime; Cephalosporins; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Penicillins; Piperacillin; Predictive Value of Tests; Respiratory Tract Infections; Thienamycins; Treatment Outcome | 1999 |
Markedly different rates and resistance profiles exhibited by seven commonly used and newer beta-lactams on the selection of resistant variants of Enterobacter cloacae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefamandole; Cefepime; Cefoperazone; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Enterobacter cloacae; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins | 1999 |
In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Carrier Proteins; Cefdinir; Cephalosporins; Dipeptidases; Drug Stability; Escherichia coli Proteins; Hexosyltransferases; Imipenem; Lactams; Levofloxacin; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Ofloxacin; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Protein Binding; Serine-Type D-Ala-D-Ala Carboxypeptidase; Thienamycins | 1999 |
Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Imipenem; Lung; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar | 1999 |
Endotoxin release due to ciprofloxacin measured by three different methods.
Topics: Anti-Infective Agents; Bacterial Toxins; Ceftazidime; Cephalosporins; Ciprofloxacin; Endotoxins; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Humans; Imipenem; Limulus Test; Lipopolysaccharides; Monocytes; Sensitivity and Specificity; Thienamycins; Tumor Necrosis Factor-alpha | 1999 |
In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
Topics: Acinetobacter; Anti-Bacterial Agents; Austria; beta-Lactam Resistance; Carbapenems; Cephalosporins; Enterobacteriaceae; Humans; Imipenem; In Vitro Techniques; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonadaceae; Tazobactam; Thienamycins | 1999 |
[Study on antibiotics susceptibility and mechanism of carbapenem-resistance in clinical isolates of Pseudomonas aeruginosa].
Topics: Anti-Infective Agents; beta-Lactam Resistance; Carbapenems; Ceftazidime; Cephalosporins; Imipenem; Meropenem; Ofloxacin; Pseudomonas aeruginosa; Thienamycins | 1999 |
Low convulsive activity of a new carbapenem antibiotic, DK-35C, as compared with existing congeners.
Topics: Animals; Carbapenems; Cefazolin; Cephalosporins; GABA Agonists; Imipenem; Injections, Intraventricular; Male; Meropenem; Mice; Mice, Inbred ICR; Muscimol; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Seizures; Synaptic Membranes; Thienamycins | 1999 |
Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans; Imipenem; Infection Control; Intensive Care Units; Paris | 1999 |
Comparison of five beta-lactam antibiotics against common nosocomial pathogens using the time above MIC at different creatinine clearances.
Topics: Anti-Bacterial Agents; Bacteria; Cefepime; Ceftazidime; Cephalosporins; Creatinine; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Models, Biological; Penicillanic Acid; Piperacillin; Tazobactam; Time Factors | 1999 |
Detection of carbapenemase-producing Acinetobacter baumannii in a hospital.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Ceftazidime; Cephalosporins; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Hospitals, University; Humans; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Thienamycins | 2000 |
[In vitro activity of biapenem (BIPM) against clinically isolated respiratory pathogens in 1996-1998].
Topics: Bacteria; Carbapenems; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Penicillins; Piperacillin; Respiratory Tract Infections; Thienamycins; Time Factors | 1999 |
[Antimicrobial activities of meropenem against clinically isolated strains in 1997].
Topics: Bacteria; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Thienamycins; Time Factors | 1999 |
Imipenem resistance of enterobacter aerogenes mediated by outer membrane permeability.
Topics: Bacterial Typing Techniques; beta-Lactamases; Cefpirome; Cell Membrane Permeability; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Fatal Outcome; France; Humans; Imipenem; Male; Microbial Sensitivity Tests; Thienamycins; Trachea; Urine | 2000 |
Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Utilization; Forecasting; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Models, Biological; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Time Factors | 2000 |
Efficacies of imipenem, meropenem, cefepime, and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing beta-lactamase-producing strain of Enterobacter cloacae.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; beta-Lactamases; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Creatinine; Drug Resistance, Microbial; Enterobacter cloacae; Enterobacteriaceae Infections; Half-Life; Imipenem; Kidney Diseases; Male; Meropenem; Penicillinase; Pneumonia, Bacterial; Protein Binding; Rats; Rats, Wistar; Thienamycins; Uranyl Nitrate | 2000 |
Differential host inflammatory responses to viable versus antibiotic-killed bacteria in experimental microbial sepsis.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ceftazidime; Cell Adhesion; Cell Movement; Cephalosporins; Dexamethasone; Endothelium, Vascular; Escherichia coli; Female; Galactosamine; Imipenem; Kinetics; Leukocytes; Male; Mice; Microcirculation; Rats; Rats, Sprague-Dawley; Sepsis; Staphylococcus aureus; Thienamycins; Time Factors; Tumor Necrosis Factor-alpha | 2000 |
[Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Teicoplanin; Vancomycin | 2000 |
In vitro activity of meropenem, imipenem, cefepime and ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Topics: Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins | 2000 |
Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal beta-lactamase and showing altered porin profiles.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Chromosomes, Bacterial; Escherichia coli; Humans; Imipenem; Microbial Sensitivity Tests; Porins | 2000 |
Imipenem therapy for septicemic melioidosis in a child with penicillin and cephalosporin adverse reaction.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Cephalosporins; Child; Diabetes Complications; Drug Therapy, Combination; Humans; Imipenem; Male; Melioidosis; Thienamycins | 2000 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
[Evaluation of antibiotics by the method of initial bactericidal activity].
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins | 2000 |
In vitro and in vivo activities of amikacin, cefepime, amikacin plus cefepime, and imipenem against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
Topics: Amikacin; Animals; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Drug Therapy, Combination; Imipenem; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Survival Analysis | 2001 |
Case-control study of risk factors for the development of enterococcal bacteremia.
Topics: Adult; Aged; Bacteremia; Case-Control Studies; Catheters, Indwelling; Cephalosporins; Cross Infection; Enterococcus; Female; Humans; Imipenem; Incidence; Male; Middle Aged; Multivariate Analysis; Neutropenia; Prospective Studies; Risk Factors; Statistics, Nonparametric; Thienamycins | 2001 |
Comparative in vitro antimicrobial activity of a new carbapenem, E1010, and tentative disc diffusion test interpretative criteria.
Topics: Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Diffusion; Enterobacteriaceae; Imipenem; Meropenem; Microbial Sensitivity Tests; Pyrrolidines; Thienamycins | 2001 |
Antimicrobial resistance surveillance of bacteria in 1999 in Korea with a special reference to resistance of enterococci to vancomycin and gram-negative bacilli to third generation cephalosporin, imipenem, and fluoroquinolone.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Enterococcus; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Korea; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Vancomycin Resistance | 2001 |
[In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
Topics: Ampicillin; Animals; beta-Alanine; Cefozopran; Ceftriaxone; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Resistance; Imipenem; Male; Meropenem; Mice; Mice, Inbred Strains; Penicillin Resistance; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2001 |
Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Cohort Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Middle Aged; Pseudomonas; Pseudomonas Infections; Statistics as Topic; Sulbactam | 2001 |
[Antimicrobial activities of carbapenems and fourth generation cephems against clinically isolated strains].
Topics: Bacteria; Carbapenems; Cefepime; Cefozopran; Cephalosporins; Imipenem; Meropenem; Thienamycins | 2001 |
In vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds.
Topics: Bacteria, Anaerobic; Carbapenems; Ceftriaxone; Cephalosporins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2002 |
Effects of parenterally administered ciprofloxacin in a murine model of pulmonary Pseudomonas aeruginosa infection mimicking ventilator-associated pneumonia.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Cefozopran; Cephalosporins; Cilastatin; Ciprofloxacin; Disease Models, Animal; Imipenem; Infusions, Parenteral; Male; Mice; Pneumonia, Bacterial; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Respiration, Artificial; Thienamycins | 2001 |
[Multicenter evaluation of the antimicrobial activity in vitro for six broad-spectrum beta-lactams in China using the E-test method].
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Cefepime; Cefoperazone; Ceftazidime; Ceftriaxone; Cephalosporins; China; Imipenem; Microbial Sensitivity Tests; Piperacillin | 2000 |
In vitro activity of meropenem and four other antibiotics against 554 clinical strains obtained from Beijing in 1999.
Topics: Anti-Bacterial Agents; Cefepime; Cefoperazone; Ceftazidime; Cephalosporins; Enterobacteriaceae; Humans; Imipenem; Meropenem; Thienamycins | 2000 |
Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates.
Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteria; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Clostridium; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma; Quinolines; Streptococcus; Teicoplanin; Thienamycins; Vancomycin | 2002 |
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins | 2001 |
Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated from pus specimens of orofacial odontogenic infections.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefazolin; Cefotaxime; Cephalosporins; Clindamycin; Corynebacterium; Drug Resistance, Bacterial; Erythromycin; Eubacterium; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Levofloxacin; Ofloxacin; Penicillins; Peptostreptococcus; Periodontitis; Staphylococcus; Streptococcus; Sulbactam; Thienamycins; Tooth Diseases | 2002 |
[Bactericidal activity of biapenem against various efflux system mutants of Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Imipenem; Meropenem; Mutation; Pseudomonas aeruginosa; Thienamycins | 2002 |
A luminescent Escherichia coli biosensor for the high throughput detection of beta-lactams.
Topics: Ampicillin; Anti-Bacterial Agents; Biosensing Techniques; Cefoxitin; Cephalosporins; Cephamycins; Cephapirin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Escherichia coli; Imipenem; Inhibitory Concentration 50; Light; Luciferases; Oxacillin; Penicillins; Piperacillin; Plasmids; Thienamycins; Time Factors | 2002 |
Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Critical Care; Cystic Fibrosis; Data Collection; Drug Resistance, Bacterial; Europe; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Population Surveillance; Proteus Infections; Proteus mirabilis; Tazobactam; Thienamycins | 2002 |
[Microbiological and clinical studies of Haemophilus influenzae isolated at Kitakyushu Municipal Medical Center from 1996 through 1999].
Topics: Adult; Aged; Ampicillin; Anti-Infective Agents; beta-Lactamases; Cefaclor; Cephalosporins; Child, Preschool; Female; Haemophilus influenzae; Humans; Imipenem; Infant; Infant, Newborn; Levofloxacin; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Respiratory System; Seasons; Sulbactam; Thienamycins | 2002 |
Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroidaceae Infections; beta-Lactams; Cefepime; Cefmetazole; Cefoperazone; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Fusobacterium; Fusobacterium Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Mouth Diseases; Penicillin G; Penicillins; Peptostreptococcus; Porphyromonas gingivalis; Prevotella; Streptococcal Infections; Streptococcus; Sulbactam | 2002 |
[The isolation of Pseudomonas aeruginosa from burn wound and the analysis of its antibiotic resistant spectrum].
Topics: Burns; Cephalosporins; Drug Resistance, Bacterial; Enzyme Induction; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2002 |
Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Brazil; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Common Bile Duct; Disease Susceptibility; Female; Gallstones; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Patient Admission; Penicillins; Treatment Outcome | 2003 |
[Bacterial resistance to antibiotics in gram-negative rods isolated from intensive care units. Comparative analysis between two periods (1998 and 2001)].
Topics: Acinetobacter; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Argentina; Cephalosporins; Child; Ciprofloxacin; Drug Resistance, Microbial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant, Newborn; Intensive Care Units; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies | 2003 |
Determination of the frequency of inadequate antibiotic therapy using calculation of indication failure (IF), cumulative indication failure (CIF), and balanced indication failure (BIF).
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Multiple; Empiricism; Enterobacteriaceae Infections; Humans; Imipenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Treatment Failure | 2003 |
Korean nationwide surveillance of antimicrobial resistance in 2000 with special reference to vancomycin resistance in enterococci, and expanded-spectrum cephalosporin and imipenem resistance in gram-negative bacilli.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Enterococcus; Gram-Negative Bacteria; Humans; Imipenem; Korea; Vancomycin Resistance | 2003 |
Lack of efflux mechanism in a clinical isolate of Pseudomonas aeruginosa highly resistant to beta-lactams and imipenem.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Biological Transport, Active; Cefepime; Ceftazidime; Ceftriaxone; Cell Membrane Permeability; Cephalosporins; Conjugation, Genetic; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Electrophoresis, Polyacrylamide Gel; Genes, Bacterial; Humans; Imipenem; Membrane Transport Proteins; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa | 2003 |
[Activity of cephems and carbapenems against clinically isolated Mycobacterium abscessus].
Topics: Carbapenems; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Thienamycins; Tuberculosis, Pulmonary | 2003 |
Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Case-Control Studies; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Logistic Models; Male; Middle Aged; Risk Factors; Thienamycins | 2004 |
Increasing prevalence of vancomycin-resistant Enterococcus faecium, expanded-spectrum cephalosporin-resistant Klebsiella pneumoniae, and imipenem-resistant Pseudomonas aeruginosa in Korea: KONSAR study in 2001.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Enterococcus faecium; Humans; Imipenem; Klebsiella pneumoniae; Korea; Pseudomonas aeruginosa; Time Factors; Vancomycin | 2004 |
[The trend and susceptibility to antibacterial agents of enterococcus species from urinary tract infections].
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Cefozopran; Cefpirome; Cephalosporins; Cilastatin; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Humans; Imipenem; Microbial Sensitivity Tests; Urinary Tract Infections | 2004 |
Resistance to imipenem, cefepime, and cefpirome associated with mutation in Omp36 osmoporin of Enterobacter aerogenes.
Topics: Bacterial Outer Membrane Proteins; Base Sequence; Cefepime; Cefpirome; Cephalosporins; DNA Primers; Drug Resistance, Microbial; Enterobacter aerogenes; Imipenem; Mutation | 2004 |
Virulence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in vitro and in vivo.
Topics: Animals; Bacteremia; beta-Lactamases; Ceftazidime; Cephalosporins; Cilastatin; Ciprofloxacin; Drug Therapy, Combination; Imipenem; Leukopenia; Male; Mice; Mice, Inbred BALB C; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Stem Cells; Thienamycins | 2004 |
Comparison of the double-disk, combined disk, and Etest methods for detecting metallo-beta-lactamases in gram-negative bacilli.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Clavulanic Acid; Culture Media, Conditioned; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Sensitivity and Specificity | 2004 |
In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
Topics: Acinetobacter baumannii; Ampicillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serratia marcescens; Sulbactam | 2004 |
Comparison of in vivo intrinsic activity of cefepime and imipenem in a Pseudomonas aeruginosa rabbit endocarditis model: effect of combination with tobramycin simulating human serum pharmacokinetics.
Topics: Animals; Anti-Bacterial Agents; Cefepime; Cephalosporins; Disease Models, Animal; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Tobramycin | 2004 |
Case report: Pseudomonas aeruginosa-related intervertebral discitis in a young boy with medulloblastoma.
Topics: Adolescent; Anti-Bacterial Agents; Antineoplastic Agents; Back Pain; Biopsy, Fine-Needle; Bone Neoplasms; Cefepime; Cephalosporins; Cerebellar Neoplasms; Cerebral Ventricle Neoplasms; Diagnosis, Differential; Discitis; Drug Therapy, Combination; Humans; Imipenem; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Medulloblastoma; Pseudomonas Infections; Thoracic Vertebrae; Treatment Outcome | 2004 |
Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Colony Count, Microbial; Guinea Pigs; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lung; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Porins; Thienamycins; Treatment Outcome | 2005 |
The cost-effectiveness of cefepime plus metronidazole versus imipenem/cilastatin in the treatment of complicated intra-abdominal infection.
Topics: Adult; Aged; APACHE; Bacterial Infections; Cefepime; Cephalosporins; Cilastatin; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Imipenem; Male; Metronidazole; Middle Aged; Probability; Retrospective Studies; Treatment Outcome | 2004 |
Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriological Techniques; Bronchoalveolar Lavage Fluid; Cephalosporins; Cross Infection; Early Diagnosis; Female; France; Humans; Imipenem; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Population Surveillance; Practice Guidelines as Topic; Prospective Studies; Pseudomonas Infections; Treatment Outcome; Ventilators, Mechanical | 2005 |
[Imipenem and cefepime in empirical therapy of infectious complications after radical surgeries in patients with invasive cancer of the urinary bladder].
Topics: Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cystectomy; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasm Staging; Postoperative Complications; Retrospective Studies; Urinary Bladder Neoplasms; Urinary Tract Infections | 2004 |
[Germs that produce the extended spectrum betalactamases].
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Emergencies; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Imipenem; Leukemia; Lymphoma, Non-Hodgkin; Male; Morocco; Neutropenia; Retrospective Studies; Shock, Septic; Time Factors | 2004 |
Efficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-Lactamase.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Disease Models, Animal; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Porins; Treatment Outcome | 2005 |
Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross Infection; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Thienamycins | 2005 |
Trough serum concentrations of beta-lactam antibiotics in cancer patients: inappropriateness of conventional schedules to pharmacokinetic/pharmacodynamic properties of beta-lactams.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Drug Administration Schedule; Female; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies | 2006 |
Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Colony Count, Microbial; Imipenem; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Plasmids; Pneumonia, Bacterial; Porins; Rats; Rats, Wistar; Thienamycins; Treatment Outcome | 2006 |
Clinical experiences of the infections caused by extended-spectrum beta-lactamase-producing Serratia marcescens at a medical center in Taiwan.
Topics: Amikacin; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Polymerase Chain Reaction; Serratia Infections; Serratia marcescens; Taiwan | 2006 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin | 2006 |
Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
Topics: Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Cefepime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Imipenem; Membrane Transport Proteins; Meropenem; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Specific Pathogen-Free Organisms; Thienamycins; Thigh; Treatment Outcome | 2007 |
Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitals.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Computer Simulation; Drug Administration Schedule; Drug Resistance, Bacterial; Humans; Hungary; Imipenem; Infusions, Intravenous; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 2006 |
Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsiella pneumoniae in Tehran.
Topics: Anti-Infective Agents; beta-Lactamases; Cefepime; Cephalosporins; Ciprofloxacin; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Female; Gentamicins; Humans; Imipenem; Iran; Klebsiella pneumoniae; Male; Meropenem; Thienamycins | 2006 |
Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis.
Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Carbapenems; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Neurosurgical Procedures; Postoperative Complications; Thienamycins; Turkey | 2007 |
Molecular epidemiology and characterization of resistance mechanisms to various antimicrobial agents in Acinetobacter baumannii isolated in Mérida, Venezuela.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Ciprofloxacin; Disease Outbreaks; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Gentamicins; Humans; Imipenem; Infant, Newborn; Tetracyclines; Venezuela | 2007 |
Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cephalosporins; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Electroporation; Ertapenem; Female; Genotype; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins; Reverse Transcriptase Polymerase Chain Reaction; Thienamycins | 2007 |
Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix.
Topics: Amino Acids; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Cloning, Molecular; Conjugation, Genetic; DNA, Bacterial; Escherichia coli; Hydrolysis; Imipenem; Kinetics; Microbial Sensitivity Tests; Mutation; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Structure-Activity Relationship; Transformation, Bacterial | 2007 |
Impact of antibiotic restriction on broad spectrum antibiotic usage in the ICU of a developing country.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Developing Countries; Drug Prescriptions; Drug Resistance, Microbial; Drug Utilization Review; Humans; Imipenem; Intensive Care Units; Medical Order Entry Systems; Organizational Policy; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Program Development; Vancomycin | 2007 |
Simultaneous determination of cefepime, vancomycin and imipenem in human plasma of burn patients by high-performance liquid chromatography.
Topics: Adolescent; Anti-Bacterial Agents; Burns; Calibration; Cefepime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Imipenem; Male; Middle Aged; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Vancomycin | 2007 |
Research and clinical value of antibacterial-application software.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Imipenem; Isosorbide Dinitrate; Male; Ofloxacin; Software | 2008 |
In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Drug Therapy, Combination; Escherichia coli; Gentamicins; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2008 |
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary | 2008 |
Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Imipenem; Porins | 2008 |
Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefepime; Cefuroxime; Cell Line; Cells, Cultured; Cephalosporins; Cloxacillin; Humans; Hydrogen-Ion Concentration; Imipenem; Meropenem; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Phagocytosis; Staphylococcus aureus; Thienamycins | 2008 |
[Epidemiological study on cigar-shaped clostridia isolated in a local Japanese general hospital].
Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Clostridium; Clostridium Infections; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals, General; Humans; Imipenem; Japan; Male; Penicillins | 2008 |
Diversity of antimicrobial use and resistance in 42 hospitals in the United States.
Topics: Anti-Bacterial Agents; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Utilization Review; Fluoroquinolones; Humans; Imipenem; Methicillin; Multivariate Analysis; United States | 2008 |
[Surveillance of multidrug resistant bacteria in a Tunisian hospital].
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Burns; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Hospitals, Urban; Humans; Imipenem; Microbial Sensitivity Tests; Practice Guidelines as Topic; Pseudomonas aeruginosa; Retrospective Studies; Sentinel Surveillance; Staphylococcus aureus; Tunisia | 2008 |
Surveillance of intrahospital infections at the clinic for gynaecology and obstetrics.
Topics: Anti-Bacterial Agents; Bosnia and Herzegovina; Cefepime; Cephalosporins; Cross Infection; Female; Humans; Imipenem; Klebsiella pneumoniae; Obstetrics and Gynecology Department, Hospital; Population Surveillance; Prevalence; Prospective Studies; Proteus mirabilis; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus; Surgical Wound Infection; Urinary Tract Infections; Vancomycin | 2009 |
Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study.
Topics: Aged; Anti-Bacterial Agents; Ascites; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Liver Cirrhosis; Male; Middle Aged; Peritonitis; Retrospective Studies; Risk Factors; Treatment Failure | 2009 |
Comparison of different methods of determining beta-lactam susceptibility in clinical strains of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Automation; Aztreonam; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Genetic Predisposition to Disease; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections | 2009 |
Emergence of extended-spectrum beta-lactamase PER-1 in Proteus vulgaris and Providencia stuartii isolates from Algiers, Algeria.
Topics: Algeria; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Imipenem; Microbial Sensitivity Tests; Piperacillin; Polymerase Chain Reaction; Proteus vulgaris; Providencia | 2009 |
[Comparative activity of ertapenem against extended-spectrum beta-lactamase-producing or plasmid-mediated AmpC beta-lactamase-producing Klebsiella pneumoniae].
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Ertapenem; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; R Factors; Substrate Specificity | 2010 |
Assessment of an alternative meropenem dosing strategy compared with imipenem-cilastatin or traditional meropenem dosing after cefepime failure or intolerance in adults with neutropenic fever.
Topics: Adult; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Dose-Response Relationship, Drug; Drug Combinations; Female; Fever; Hospital Mortality; Humans; Imipenem; Male; Meropenem; Middle Aged; Neutropenia; Retreatment; Seizures; Thienamycins; Time Factors | 2009 |
First isolation of a VIM-producing Klebsiella pneumoniae from a seven-year-old child in Venezuela.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Child; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Quinolones; Thienamycins; Urine; Venezuela | 2008 |
Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Gentamicins; Humans; Imipenem; Integrons; Meropenem; Molecular Sequence Data; Penicillanic Acid; Piperacillin; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam; Thienamycins | 2009 |
Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23 beta-lactamase in a tertiary care hospital in Korea.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Humans; Imipenem; Korea; Microbial Sensitivity Tests | 2009 |
Affinity of the new cephalosporin CXA-101 to penicillin-binding proteins of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ceftazidime; Cephalosporins; Electrophoresis, Polyacrylamide Gel; Imipenem; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Pseudomonas aeruginosa | 2010 |
Cefditoren versus ceftazidime in inducer-substrate combinations for the evaluation of AmpC production in a disc approximation test.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Enterobacteriaceae; Humans; Imipenem; Microbial Sensitivity Tests; Species Specificity | 2010 |
Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in Lebanon: a report of three cases.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Clarithromycin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Lebanon; Levofloxacin; Male; Ofloxacin; Pneumococcal Infections; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Vancomycin | 2010 |
In vitro activity of ceftaroline against a broad spectrum of recent clinical anaerobic isolates.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria, Anaerobic; Ceftaroline; Ceftriaxone; Cephalosporins; Clindamycin; Fluoroquinolones; Imipenem; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Quinolines; Tigecycline | 2011 |
Molecular analysis of antimicrobial agent translocation through the membrane porin BpsOmp38 from an ultraresistant Burkholderia pseudomallei strain.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Outer Membrane Proteins; beta-Lactams; Biological Transport; Burkholderia pseudomallei; Cefepime; Ceftazidime; Cephalosporins; Ertapenem; Humans; Imipenem; Kinetics; Lipid Bilayers; Melioidosis; Meropenem; Models, Molecular; Molecular Sequence Data; Norfloxacin; Penicillin G; Phospholipids; Porins; Protein Conformation; Sequence Homology, Amino Acid; Thienamycins | 2011 |
Biochemical and structural characterization of the subclass B1 metallo-β-lactamase VIM-4.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cephalothin; Crystallography, X-Ray; Escherichia coli; Imipenem; Magnetic Resonance Spectroscopy; Meropenem; Penicillin G; Thienamycins | 2011 |
Bacteriology of infection in severe acute pancreatitis.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Cephalosporins; Comorbidity; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Longitudinal Studies; Male; Middle Aged; Outcome Assessment, Health Care; Pancreatitis; Prevalence; Prospective Studies; Severity of Illness Index; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2011 |
Activity of ACHN-490 tested alone and in combination with other agents against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Doripenem; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa | 2011 |
Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Imipenem; Membrane Transport Proteins; Meropenem; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa; Reverse Transcriptase Polymerase Chain Reaction; Thienamycins | 2011 |
The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey.
Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Cost Savings; Cross Infection; Drug Costs; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization; Escherichia; Health Policy; Hospitals; Humans; Imipenem; Klebsiella; Meropenem; Methicillin Resistance; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Staphylococcus aureus; Teicoplanin; Thienamycins; Turkey; Vancomycin | 2011 |
[Assessment of efficacies of imipenem, cefoperazone-sulbactam and cefepime in rats with experimental thigh abscess model with multidrug resistant and susceptible Acinetobacter baumannii strains].
Topics: Abscess; Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Cefepime; Cefoperazone; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Imipenem; Random Allocation; Rats; Rats, Wistar; Serum Bactericidal Test; Soft Tissue Infections; Sulbactam; Thigh | 2011 |
Inhibitory effects of various essential oils and individual components against extended-spectrum beta-lactamase (ESBL) produced by Klebsiella pneumoniae and their chemical compositions.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Food Preservatives; Gas Chromatography-Mass Spectrometry; Imipenem; Klebsiella pneumoniae; Lamiaceae; Mentha piperita; Microbial Sensitivity Tests; Ocimum basilicum; Ofloxacin; Oils, Volatile; Origanum; Plant Extracts; Satureja | 2011 |
Characterization of a novel IMP-28 metallo-β-lactamase from a Spanish Klebsiella oxytoca clinical isolate.
Topics: Amino Acid Sequence; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; DNA-Binding Proteins; DNA, Bacterial; Histones; Humans; Imipenem; Integrons; Klebsiella oxytoca; Meropenem; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Sequence Alignment; Spain; Thienamycins | 2012 |
Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Binding Sites; Carbapenems; Ceftazidime; Cephalosporins; Cross Infection; Gene Expression; Humans; Imipenem; Kinetics; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Protein Binding; Protein Isoforms; Pseudomonas aeruginosa; Pseudomonas Infections | 2012 |
Microbiologic characteristics of pathogenic bacteria from hospitalized trauma patients who survived Wenchuan earthquake.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Child; China; Disasters; Drug Resistance, Bacterial; Earthquakes; Female; Gram-Negative Bacteria; Gram-Positive Cocci; Hospitalization; Humans; Imipenem; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Survival; Trauma Centers; Wounds and Injuries; Young Adult | 2012 |
[Microbiological monitoring in therapy of patients with iatrogenic esophageotracheal fistula].
Topics: Acetamides; Anti-Bacterial Agents; Candida; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Follow-Up Studies; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Iatrogenic Disease; Imipenem; Intubation, Intratracheal; Linezolid; Microbial Sensitivity Tests; Monitoring, Physiologic; Oxazolidinones; Polymyxin B; Pseudomonas aeruginosa; Respiratory Tract Infections; Staphylococcus aureus; Staphylococcus epidermidis; Tracheoesophageal Fistula; Vancomycin | 2012 |
Functional characterization of a novel Mn2+ dependent protein serine/threonine kinase KpnK, produced by Klebsiella pneumoniae strain MGH78578.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Cations, Divalent; Cephalosporins; Coenzymes; Drug Resistance, Multiple, Bacterial; Escherichia coli; Gene Deletion; Gene Expression; Hydrogen-Ion Concentration; Imipenem; Klebsiella pneumoniae; Manganese; Microbial Sensitivity Tests; Molecular Sequence Data; Phosphorylation; Protein Serine-Threonine Kinases; Recombinant Proteins; Signal Transduction; Stress, Physiological | 2012 |
Repeated colonization by multi-drug-resistant Acinetobacter calcoaceticus-A. baumannii complex and changes in antimicrobial susceptibilities in surgical intensive care units.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Cefepime; Cephalosporins; Chi-Square Distribution; China; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Care; Cross Infection; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Public Health Surveillance; Retrospective Studies | 2013 |
Phenotypic and molecular characterization of extended-spectrum β-lactamases and AmpC β-lactamases in Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Egypt; Genotype; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Phenotype; Polymerase Chain Reaction; Sequence Analysis, DNA; Tigecycline | 2013 |
When pharmacodynamics trump costs: an antimicrobial stewardship program's approach to selecting optimal antimicrobial agents.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Doripenem; Drug Costs; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 2013 |
Evaluation of Ertapenem use with impact assessment on extended-spectrum beta-lactamases (ESBL) production and gram-negative resistance in Singapore General Hospital (SGH).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, General; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Singapore; Thienamycins; Young Adult | 2013 |
[Analysis of the carbapenemase-producing mechanism of Enterobacteriaceae with decreased susceptibility to carbapenems].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Enterobacteriaceae; Ertapenem; Gene Amplification; Imipenem; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Thienamycins | 2013 |
Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Imipenem; Meropenem; Microbial Sensitivity Tests; Mutation; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Thienamycins | 2014 |
Molecular and epidemiological characterization of IMP-type metallo-β-lactamase-producing Enterobacter cloacae in a Large tertiary care hospital in Japan.
Topics: Aged; Aged, 80 and over; Bacteremia; Bacterial Proteins; beta-Lactamases; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Hospital Mortality; Humans; Imipenem; Infection Control; Inosine Monophosphate; Japan; Male; Meropenem; Middle Aged; Phylogeny; R Factors; Retrospective Studies; Risk Factors; Tertiary Healthcare; Thienamycins | 2014 |
In vivo efficacy of ceftolozane against Pseudomonas aeruginosa in a rabbit experimental model of pneumonia: comparison with ceftazidime, piperacillin/tazobactam and imipenem.
Topics: Animal Structures; Animals; Anti-Bacterial Agents; Bacterial Load; Ceftazidime; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Female; Humans; Imipenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Treatment Outcome | 2014 |
The impact of an antimicrobial stewardship programme on the use of antimicrobials and the evolution of drug resistance.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cephalosporins; Drug Resistance, Microbial; Drug Utilization; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pharmacy Service, Hospital; Practice Patterns, Physicians'; Program Evaluation; Pseudomonas aeruginosa; Spain; Thienamycins | 2015 |
Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cephalosporins; China; Drug Resistance, Bacterial; Gram-Negative Bacteria; Hospitals, University; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins | 2015 |
War wound treatment complications due to transfer of an IncN plasmid harboring bla(OXA-181) from Morganella morganii to CTX-M-27-producing sequence type 131 Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Imipenem; Microbial Sensitivity Tests; Morganella morganii; Plasmids | 2015 |
Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cephalosporins; Ciprofloxacin; Cross Infection; Female; Hospitals; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Mortality; Multivariate Analysis; Odds Ratio; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Severity of Illness Index; Taiwan; Thienamycins | 2017 |
Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs Healthcare System.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cefepime; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ertapenem; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; United States; United States Department of Veterans Affairs | 2015 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection | 2016 |
Interspecies scaling of excretory amounts using allometry - retrospective analysis with rifapentine, aztreonam, carumonam, pefloxacin, miloxacin, trovafloxacin, doripenem, imipenem, cefozopran, ceftazidime, linezolid for urinary excretion and rifapentine,
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Doripenem; Feces; Fluoroquinolones; Heterocyclic Compounds, 3-Ring; Humans; Imipenem; Linezolid; Naphthyridines; Oxazines; Oxolinic Acid; Pefloxacin; Piperazines; Pyridones; Retrospective Studies; Rifampin | 2016 |
Antibiotic Resistance Patterns of Gram-Negative Psychrotrophic Bacteria from Bulk Tank Milk.
Topics: Animals; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Food Microbiology; Gram-Negative Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Milk; Pseudomonadaceae; Thienamycins | 2016 |
Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cephalosporins; Drug Therapy, Combination; Female; Humans; Imipenem; Immunosuppressive Agents; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Retrospective Studies; Survival Analysis; Thienamycins; Treatment Outcome | 2016 |
In Vivo and In Vitro Efficacy of Minocycline-Based Combination Therapy for Minocycline-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Biofilms; Cefepime; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gentamicins; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Taiwan; Thienamycins | 2016 |
Rapid increase in resistance to third generation cephalosporins, imipenem and co-resistance in Klebsiella pneumoniae from isolated from 7,140 blood-cultures (2010-2014) using EARS-Net data in Spain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Catchment Area, Health; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Population Surveillance; Spain; Young Adult | 2017 |
Involvement of the Multidrug Efflux Pumps in Betalactams Resistant Pseudomonas aerugionsa Clinical Isolates Collected from Burn Patients in Iran.
Topics: Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; Burns; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cefepime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Genes, MDR; Humans; Imipenem; Iran; Membrane Transport Proteins; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections | 2016 |
[Study on drug sensitivity against Comamonas testosteroni by Kirby-Bauer disk diffusion method].
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Comamonas testosteroni; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Thienamycins | 2016 |
Risk Factor Analysis of Ciprofloxacin-Resistant and Extended Spectrum Beta-Lactamases Pathogen-Induced Acute Bacterial Prostatitis in Korea.
Topics: Acute Disease; Adult; Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Prostatitis; Republic of Korea; Retrospective Studies; Risk Factors | 2016 |
Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Asia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacter; Ertapenem; Gram-Negative Bacteria; Hospitalization; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Urinary Tract Infections | 2017 |
Development of an algorithm for phenotypic screening of carbapenemase-producing Enterobacteriaceae in the routine laboratory.
Topics: Algorithms; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Clavulanic Acids; Drug Resistance, Bacterial; Enterobacteriaceae; Ertapenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Tazobactam; Thienamycins; Ticarcillin | 2017 |
Trends in Drug Resistance of
Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Cefepime; Cefoperazone; Ceftazidime; Cephalosporins; China; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2017 |
IMI-2 carbapenemase in a clinical Klebsiella variicola isolated in the UK.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Ertapenem; Gene Transfer, Horizontal; Humans; Imipenem; Klebsiella; Meropenem; Plasmids; Thienamycins; United Kingdom | 2017 |
In vitro interaction of ceftazidime-avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Ceftazidime; Cephalosporins; Drug Combinations; Ertapenem; Gentamicins; Humans; Imipenem; Italy; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Minocycline; Thienamycins; Tigecycline | 2017 |
Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; Cephalosporins; Drug Stability; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Mutation; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Thienamycins | 2017 |
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2017 |
The mechanism of NDM-1-catalyzed carbapenem hydrolysis is distinct from that of penicillin or cephalosporin hydrolysis.
Topics: beta-Lactamases; Carbapenems; Cephalosporins; Crystallization; Crystallography, X-Ray; Escherichia coli; Hydrolysis; Imipenem; Magnetic Resonance Spectroscopy; Meropenem; Models, Molecular; Penicillins; Thienamycins | 2017 |
Prevention of High-Level Daptomycin-Resistance Emergence In Vitro in Streptococcus mitis-oralis by Using Combination Antimicrobial Strategies.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Combinations; Drug Resistance, Bacterial; Gentamicins; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Rifampin; Streptococcus mitis; Streptococcus oralis; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Outbreak of IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean).
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Colistin; Comoros; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Genome, Bacterial; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Young Adult | 2018 |
[Analysis of the distribution characteristics and drug resistance of non-fermenting bacterial infection in intensive care unit from 2009 to 2015]
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cefoperazone; Cephalosporins; Cross Infection; Drug Resistance; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Retrospective Studies; Thienamycins | 2016 |
Stability and low induction propensity of cefiderocol against chromosomal AmpC β-lactamases of Pseudomonas aeruginosa and Enterobacter cloacae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefiderocol; Cephalosporins; Chromosomes, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2018 |
AmpC beta-lactamases in Klebsiella pneumoniae: An emerging threat to the paediatric patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefoperazone; Cefoxitin; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Pakistan; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2018 |
In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Stenotrophomonas maltophilia; Taiwan; Tazobactam | 2019 |
Differential active site requirements for NDM-1 β-lactamase hydrolysis of carbapenem versus penicillin and cephalosporin antibiotics.
Topics: Ampicillin; beta-Lactamases; Carbapenems; Catalytic Domain; Cefotaxime; Cephalosporins; Codon; Drug Resistance, Bacterial; Escherichia coli; High-Throughput Nucleotide Sequencing; Imipenem; Mutation; Penicillins | 2018 |
The Occurrence of bla
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Bacterial; Humans; Imipenem; Iran; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nalidixic Acid; Trimethoprim, Sulfamethoxazole Drug Combination | 2020 |
Effect of Amoxicillin in combination with Imipenem-Relebactam against Mycobacterium abscessus.
Topics: Amoxicillin; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Cephalosporins; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Imipenem; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Plasmids | 2020 |
Characterization of AmpC β-lactamase mutations of extensively drug-resistant Pseudomonas aeruginosa isolates that develop resistance to ceftolozane/tazobactam during therapy.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2020 |
In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Clinical Isolates of Gram-negative Bacilli With Difficult-to-Treat Resistance and Multidrug-resistant Phenotypes-Study for Monitoring Antimicrobial Resistance Trends, United State
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Cephalosporins; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; United States | 2021 |
Gram-negative Bacteria With Difficult-to-Treat Resistance: A Moving Target.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Imipenem; Phenotype; Tazobactam | 2021 |
Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Germany; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2020 |
Expression of CTX-M-15 limits the efficacy of ceftolozane/tazobactam against Escherichia coli in a high-inoculum murine peritonitis model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Cephalosporins; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Imipenem; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Peritonitis; Tazobactam | 2020 |
Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, bla
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Genotype; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Sisomicin; Young Adult | 2021 |
Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa from patients hospitalized with pneumonia in European medical centers in 2020.
Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Hospitalization; Humans; Imipenem; Jupiter; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2022 |
Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infections.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Boronic Acids; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Soft Tissue Infections; Tazobactam | 2021 |
Activity of imipenem-relebactam and ceftolozane-tazobactam against carbapenem-resistant Pseudomonas aeruginosa and KPC-producing Enterobacterales.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tazobactam | 2022 |
Comparative analysis of in vitro dynamics and mechanisms of ceftolozane/tazobactam and imipenem/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Cephalosporins; Clone Cells; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2022 |
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Combinations; Hospitals; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; United States | 2022 |
T405, a New Penem, Exhibits
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous | 2022 |
Genome characterization of a Klebsiella pneumoniae co-producing OXA-181 and KPC-121 resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam and cefiderocol isolated from a critically ill patient.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Boronic Acids; Cefiderocol; Ceftazidime; Cephalosporins; Critical Illness; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2022 |
Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Borinic Acids; Carboxylic Acids; Cefepime; Cefiderocol; Ceftazidime; Cephalosporins; Cyclooctanes; Humans; Imipenem; Piperidines; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2022 |
Clinical Characteristics and Drug Resistance Analysis of 90 Cases of Children with Salmonella Enteritis.
Topics: Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Child; Drug Resistance; Enteritis; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Piperacillin; Retrospective Studies | 2022 |
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Escherichia coli; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2022 |
In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program.
Topics: Ampicillin; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftaroline; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Klebsiella pneumoniae; Levofloxacin; Meropenem; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Piperacillin; Tazobactam; Tigecycline | 2022 |
Activity of newest generation β-lactam/β-lactamase inhibitor combination therapies against multidrug resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Monobactams; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2022 |
Evolution of Beta-Lactamases in Urinary Klebsiella pneumoniae Isolates from Croatia; from Extended-Spectrum Beta-Lactamases to Carbapenemases and Colistin Resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Colistin; Croatia; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2022 |
Prevalence of Efflux Pump and Porin-Related Antimicrobial Resistance in Clinical
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefazolin; Cefepime; Cefoxitin; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Resistance, Bacterial; Ertapenem; Humans; Imipenem; Iraq; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; Prevalence | 2022 |
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical gram-negative isolates from Czech Republic, Hungary, and Poland-SMART 2017-2020.
Topics: Anti-Bacterial Agents; Cephalosporins; Czech Republic; Humans; Hungary; Imipenem; Microbial Sensitivity Tests; Poland; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2023 |
Biochemical Insights into Imipenem Collateral Susceptibility Driven by
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Drug Combinations; Humans; Imipenem; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2023 |
Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa isolates from US medical centres (2020-2021).
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Ceftazidime; Cephalosporins; Drug Combinations; Hospitals; Humans; Imipenem; Lactams; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2023 |
Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Ceftazidime; Cephalosporinase; Cephalosporins; Drug Combinations; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2023 |
In vitro activities of ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveil
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Doripenem; Humans; Imipenem; Leadership; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2023 |